Sabra Health Care REIT (SBRA) 10-Q 4 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document	9 Months Ended
	Sep. 30, 2014	Oct. 31, 2014
Entity Information [Line Items]	'	'
Entity Registrant Name	'Sabra Health Care REIT, Inc.	'
Entity Central Index Key	'0001492298	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	54,527,984

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets	'	'
Real estate investments, net of accumulated depreciation of $179,301 and $151,078 as of September 30, 2014 and December 31, 2013, respectively	$1,568,268	$915,418
Loans receivable and other investments, net	250,674	185,293
Cash and cash equivalents	25,479	4,308
Restricted cash	6,537	5,352
Deferred tax assets	24,212	24,212
Prepaid expenses, deferred financing costs and other assets	142,196	63,252
Total assets	2,017,366	1,197,835
Liabilities	'	'
Mortgage notes	124,714	141,328
Secured revolving credit facility	614,000	135,500
Senior unsecured notes	550,000	414,402
Accounts payable and accrued liabilities	40,719	22,229
Tax liability	24,212	24,212
Total liabilities	1,353,645	737,671
Commitments and contingencies (Note 12)	'	'
Equity	'	'
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 issued and outstanding as of September 30, 2014 and December 31, 2013	58	58
Common stock, $.01 par value; 125,000,000 shares authorized, 47,627,984 and 38,788,745 shares issued and outstanding as of September 30, 2014 and December 31, 2013, respectively	476	388
Additional paid-in capital	771,844	534,639
Cumulative distributions in excess of net income	-108,628	-74,921
Total Sabra Health Care REIT. Inc. stockholders’ equity	663,750	460,164
Noncontrolling interests	-29	0
Total equity	663,721	460,164
Total liabilities and equity	$2,017,366	$1,197,835

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parentheticals) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Assets	'	'
Accumulated depreciation	$179,301	$151,078
Equity	'	'
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	5,750,000	5,750,000
Preferred stock, shares outstanding	5,750,000	5,750,000
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	47,627,984	38,788,745
Common stock, shares outstanding	47,627,984	38,788,745

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (Loss) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues:	'	'	'	'
Rental income	$38,165	$31,699	$111,743	$94,692
Interest and other income	5,819	1,227	16,064	2,531
Total revenues	43,984	32,926	127,807	97,223
Expenses:	'	'	'	'
Depreciation and amortization	9,762	8,258	28,867	24,726
Interest	10,540	9,739	32,668	29,884
General and administrative	6,226	3,057	20,005	11,196
Total expenses	26,528	21,054	81,540	65,806
Loss on extinguishment of debt	-158	-351	-22,454	-10,101
Other income (expense)	-100	300	860	-600
Total other income (expense)	-258	-51	-21,594	-10,701
Net income	17,198	11,821	24,673	20,716
Net loss attributable to noncontrolling interests	6	0	29	0
Net income attributable to Sabra Health Care REIT, Inc	17,204	11,821	24,702	20,716
Preferred stock dividends	-2,561	-2,579	-7,682	-5,406
Net income attributable to common stockholders	$14,643	$9,242	$17,020	$15,310
Basic common share	$0.31	$0.25	$0.39	$0.41
Diluted common share	$0.31	$0.24	$0.39	$0.41
Weighted-average number of common shares outstanding, basic	47,359,949	37,358,334	43,358,620	37,334,120
Weighted-average number of common shares outstanding, diluted	47,877,202	37,828,573	43,840,550	37,777,458

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Equity (USD $)

Total

Preferred Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Cumulative Distributions in Excess of Net Income [Member]

Total Stockholders' Equity Before Noncontrolling Interests [Member]

Noncontrolling Interest [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

In Thousands, except Share data, unless otherwise specified

Additional Paid-in Capital [Member]

Total Stockholders' Equity Before Noncontrolling Interests [Member]

Additional Paid-in Capital [Member]

Total Stockholders' Equity Before Noncontrolling Interests [Member]

Beginning balance at Dec. 31, 2012

$305,488

$0

$371

$353,861

($48,744)

$305,488

$0

'

'

'

'

'

'

'

Beginning balance (shares) at Dec. 31, 2012

'

0

37,099,209

'

'

'

'

'

'

'

'

'

'

'

Increase (Decrease) in Stockholders' Equity [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net income

20,716

'

'

'

20,716

20,716

0

'

'

'

'

'

'

'

Amortization of stock based compensation

5,693

'

'

5,693

'

5,693

'

'

'

'

'

'

'

'

Stock issuance, Value

'

58

'

'

'

'

'

138,257

138,199

138,257

-2,949

2

-2,951

-2,949

Stock issuance, Shares

'

5,750,000

'

'

'

'

'

'

'

'

'

234,734

'

'

Dividends, Preferred Stock, Cash

'

'

'

'

-5,406

-5,406

'

'

'

'

'

'

'

'

Common dividends

-38,609

'

'

'

-38,609

-38,609

'

'

'

'

'

'

'

'

Ending balance at Sep. 30, 2013

423,190

58

373

494,802

-72,043

423,190

0

'

'

'

'

'

'

'

Ending balance (shares) at Sep. 30, 2013

'

5,750,000

37,333,943

'

'

'

'

'

'

'

'

'

'

'

Beginning balance at Dec. 31, 2013

460,164

58

388

534,639

-74,921

460,164

0

'

'

'

'

'

'

'

Beginning balance (shares) at Dec. 31, 2013

'

5,750,000

38,788,745

'

'

'

'

'

'

'

'

'

'

'

Increase (Decrease) in Stockholders' Equity [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net income

24,673

'

'

'

24,702

24,702

-29

'

'

'

'

'

'

'

Amortization of stock based compensation

7,092

'

'

7,092

'

7,092

'

'

'

'

'

'

'

'

Stock issuance, Value

'

'

'

'

'

'

'

'

'

'

230,201

88

230,113

230,201

Stock issuance, Shares

'

'

'

'

'

'

'

'

'

'

'

8,839,239

'

'

Dividends, Preferred Stock, Cash

'

'

'

'

-7,682

-7,682

'

'

'

'

'

'

'

'

Common dividends

-50,727

'

'

'

-50,727

-50,727

'

'

'

'

'

'

'

'

Ending balance at Sep. 30, 2014

$663,721

$58

$476

$771,844

($108,628)

$663,750

($29)

'

'

'

'

'

'

'

Ending balance (shares) at Sep. 30, 2014

'

5,750,000

47,627,984

'

'

'

'

'

'

'

'

'

'

'

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Equity (Parenthetical) (USD $)	0 Months Ended			9 Months Ended
	Jul. 30, 2014	5-May-14	Jan. 23, 2014	Sep. 30, 2014	Sep. 30, 2013
Common dividends	$0.38	$0.38	$0.36	$1.12	$1.02

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net income	$24,673	$20,716
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	28,867	24,726
Non-cash interest income adjustments	217	29
Amortization of deferred financing costs	2,812	2,395
Stock-based compensation expense	6,337	5,209
Amortization of premium	-33	-535
Loss on extinguishment of debt	1,576	858
Straight-line rental income adjustments	-13,074	-10,836
Write-off of straight-line rental income	2,994	0
Change in fair value of contingent consideration	-860	600
Changes in operating assets and liabilities:	'	'
Prepaid expenses and other assets	-2,529	-1,494
Accounts payable and accrued liabilities	22,607	10,413
Restricted cash	-2,348	-2,870
Net cash provided by operating activities	71,239	49,211
Cash flows from investing activities:	'	'
Acquisitions of real estate	-721,879	-6,175
Origination and fundings of loans receivable	-59,256	-26,393
Preferred equity investment	-11,300	-6,624
Additions to real estate	-1,151	-388
Repayment of loans receivable	287	0
Net proceeds from the sale of real estate	0	2,208
Net cash used in investing activities	-793,299	-37,372
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	350,000	200,000
Principal payments on senior unsecured notes	-211,250	-113,750
Proceeds from revolving credit facility	699,000	0
Payments on revolving credit facility	-220,500	-92,500
Proceeds from mortgage notes	57,703	0
Principal payments on mortgage notes	-88,419	-10,081
Payments of deferred financing costs	-15,474	-8,598
Issuance of preferred stock	0	138,257
Issuance of common stock	229,825	-2,950
Dividends paid on common and preferred stock	-57,654	-42,677
Net cash provided by financing activities	743,231	67,701
Net increase in cash and cash equivalents	21,171	79,540
Cash and cash equivalents, beginning of period	4,308	17,101
Cash and cash equivalents, end of period	25,479	96,641
Supplemental disclosure of cash flow information:	'	'
Interest paid	26,705	21,937
Assumption of mortgage indebtedness	14,102	0
Repayment of preferred equity investments	$6,949	$0

BUSINESS

BUSINESS	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Business	'
	BUSINESS
	Overview
	Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Old Sun”) and commenced operations on November 15, 2010. Sabra elected to be treated as a real estate investment trust (“REIT”) with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. Sabra believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner, or by subsidiaries of the Operating Partnership. The Company’s investment portfolio is primarily comprised of skilled nursing/transitional care facilities, senior housing facilities, acute care hospitals, debt investments and preferred equity investments.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of Consolidation and Basis of Presentation
	The condensed consolidated financial statements include the accounts of Sabra, its wholly owned subsidiaries and a consolidated variable interest entity (“VIEs”). All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
	GAAP requires the Company to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of VIEs. A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity's equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary.
	The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis.
	As of September 30, 2014, the Company determined it was the primary beneficiary of one senior housing facility and has consolidated the operations of the facility in the accompanying condensed consolidated financial statements. As of September 30, 2014, the operations of the facility were not material to the Company’s results of operations, financial condition or cash flows.
	As it relates to investments in loans, in addition to the Company's assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine if the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower's expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At September 30, 2014, none of the Company's investments in loans are accounted for as real estate joint ventures.
	As it relates to investments in joint ventures, based on the type of rights held by the limited partner(s), GAAP may preclude consolidation by the sole general partner in certain circumstances in which the general partner would otherwise consolidate the joint venture. The Company assesses limited partners' rights and their impact on the presumption of control of the limited partnership by the sole general partner when an investor becomes the sole general partner, and the Company reassesses if: there is a change to the terms or in the exercisability of the rights of the limited partners; the sole general partner increases or decreases its ownership of limited partnership interests; or there is an increase or decrease in the number of outstanding limited partnership interests. The Company also applies this guidance to managing member interests in limited liability companies.
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information as contained within the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”), including the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for financial statements. In the opinion of management, the financial statements for the unaudited interim periods presented include all adjustments, which are of a normal and recurring nature, necessary for a fair statement of the results for such periods. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information, refer to the Company’s consolidated financial statements and notes thereto for the year ended December 31, 2013 included in the Company’s 2013 Annual Report on Form 10-K filed with the SEC.
	Use of Estimates
	The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
	Recently Issued Accounting Standards Update
	In April 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU No. 2014-08”), which changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. The standard no longer precludes presentation as a discontinued operation if (i) there are operations and cash flows of the component that have not been eliminated from the reporting entity’s ongoing operations, or (ii) there is significant continuing involvement with a component after its disposal. ASU No. 2014-08 is effective for public entities for interim and annual periods beginning after December 15, 2014, and will be applied prospectively.  The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.
	In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to a customer at an amount reflecting the consideration it expects to receive in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. Additionally, this guidance requires improved disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance specifically notes that lease contracts with customers are a scope exception. ASU 2014-09 is effective for the first interim period within annual reporting periods beginning after December 15, 2016, and early adoption is not permitted. The Company is currently in the process of evaluating the impact the adoption of ASU 2014-09 will have on the Company’s financial position or results of operations.
	In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” ASU 2014-15 requires management to evaluate whether there are conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, and to provide certain disclosures when it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued. ASU 2014-15 is effective for the annual period ended December 31, 2016 and for annual periods and interim periods thereafter with early adoption permitted. The adoption of ASU 2014-15 is not expected to materially impact the Company’s consolidated financial statements.

RECENT_REAL_ESTATE_ACQUISITION

RECENT REAL ESTATE ACQUISITIONS (Notes)	9 Months Ended
	Sep. 30, 2014
RECENT REAL ESTATE ACQUISITIONS [Abstract]	'
Recent Real Estate Acquisitions	'
	RECENT REAL ESTATE ACQUISITIONS
	During the nine months ended September 30, 2014, the Company acquired six skilled nursing/transitional care facilities and 27 senior housing facilities for consideration totaling $690.8 million. The consideration was allocated as follows (in thousands):
					Intangibles
	Land		Building and Improvements		Tenant Origination and Absorption Costs		Tenant Relationship		Total Consideration
	$	54,387	$	625,536	$	7,924	$	2,991	$	690,838
	As of September 30, 2014, the purchase price allocations for the acquisitions completed during the three months ended September 30, 2014 are preliminary pending the receipt of information necessary to complete the valuation of certain tangible and intangible assets and liabilities and therefore are subject to change.
	The tenant origination and absorption costs intangible assets and tenant relationship intangible assets acquired in connection with these acquisitions have weighted-average amortization periods as of the date of acquisition of 14 years and 24 years, respectively.
	For the three and nine months ended September 30, 2014, the Company recognized $3.9 million and $8.3 million, respectively, of total revenues and $1.0 million and $3.3 million, respectively, of net income attributable to common stockholders from these properties.
	Holiday Portfolio
	On September 25, 2014, the Company acquired a portfolio of 21 independent living facilities (the “Holiday Portfolio”), located in 15 states, from affiliates of Holiday Acquisition Holdings Corp. (“Holiday”) for a total cash purchase price of $550.0 million. Concurrently with the acquisition, certain wholly owned subsidiaries of the Company entered into a triple-net master lease agreement with certain wholly-owned subsidiaries of Holiday AL Holdings LP (collectively, “Holiday Tenant”), an affiliate of Holiday. The master lease has an initial term of 15 years with two five-year renewal options and provides for base rent in the first year of approximately $30.3 million, with annual rent increases of 4.0% in years two and three and the greater of 3.5% or the change in the Consumer Price Index during the remainder of the lease term. The master lease is expected to generate annual lease revenues determined in accordance with GAAP, of $39.3 million. The closing of the acquisition of one facility was deferred until October 7, 2014 and Holiday Tenant agreed to pay the full rental amount due under the lease notwithstanding the delay in the closing of the acquisition of this facility.
	Acquisition Earn-Out
	On February 14, 2014, the Company acquired four skilled nursing facilities and two senior housing facilities (the “Nye Portfolio”) for $90.0 million. The Company may pay an earn-out based on incremental portfolio value created through the improvement of current operations as well as through expansion and conversion projects associated with these facilities. The earn-out amount will be determined based on portfolio performance following the third anniversary of the master lease. To determine the value of the contingent consideration, the Company used significant inputs not observable in the market to estimate the earn-out, made assumptions regarding the probability of the portfolio achieving the incremental value and then applied an appropriate discount rate. The Company estimated a contingent consideration liability of $3.2 million at the time of purchase. As of September 30, 2014, based on the potential future performance of the Nye Portfolio, the contingent consideration liability is estimated at $3.4 million and is included in accounts payable and accrued liabilities in the accompanying condensed consolidated balance sheet. During the three and nine months ended September 30, 2014, the Company recorded an adjustment to the contingent consideration liability of $0.1 million and $0.2 million, respectively, and included this amount in Other (expense) income on the accompanying condensed consolidated statements of income.

REAL_ESTATE_INVESTMENTS

REAL ESTATE INVESTMENTS	9 Months Ended
	Sep. 30, 2014
Real Estate Investments, Net [Abstract]	'
Real Estate Investments	'
	REAL ESTATE PROPERTIES HELD FOR INVESTMENT
	The Company’s real estate properties held for investment consisted of the following (dollars in thousands):
	As of September 30, 2014
	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Transitional Care		102		11,460			$	825,378	$	(151,842	)	$	673,536
	Senior Housing		50		4,818			746,130		(17,395		)	728,735
	Acute Care Hospitals		2		124			175,807		(9,873		)	165,934
			154		16,402			1,747,315		(179,110		)	1,568,205
	Corporate Level							254		(191		)	63
								$	1,747,569	$	(179,301	)	$	1,568,268
	As of December 31, 2013
	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Transitional Care		96		10,826			$	737,188	$	(132,068	)	$	605,120
	Senior Housing		23		1,518			153,247		(13,337		)	139,910
	Acute Care Hospitals		2		124			175,807		(5,520		)	170,287
			121		12,468			1,066,242		(150,925		)	915,317
	Corporate Level							254		(153		)	101
								$	1,066,496	$	(151,078	)	$	915,418
		September 30, 2014			December 31, 2013
	Building and improvements	$	1,476,202		$	879,926
	Furniture and equipment	80,977			50,567
	Land improvements	4,392			4,392
	Land	185,998			131,611
		1,747,569			1,066,496
	Accumulated depreciation	(179,301		)	(151,078		)
		$	1,568,268		$	915,418
	Operating Leases
	As of September 30, 2014, all of the Company’s real estate properties were leased under triple-net operating leases with expirations ranging from six to 18 years. As of September 30, 2014, the leases had a weighted-average remaining term of 11 years. The leases include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. In addition, the Company may receive additional security under these operating leases in the form of letters of credit and security deposits from the lessee or guarantees from the parent of the lessee or other related parties. Security deposits received in cash related to tenant leases are included in accounts payable and accrued liabilities in the accompanying condensed consolidated balance sheets and totaled $15.6 million and $1.6 million as of September 30, 2014 and December 31, 2013, respectively. As of September 30, 2014, 81 of the Company's 154 real estate properties held for investment were leased to subsidiaries of Genesis.
	The Company monitors the creditworthiness of its tenants by reviewing credit ratings (if available) and evaluating the ability of the tenants to meet their lease obligations to the Company based on the tenants’ financial performance, including the evaluation of any parent guarantees (or the guarantees of other related parties) of tenant lease obligations. Because formal credit ratings may not be available for most of the Company’s tenants, the primary basis for the Company’s evaluation of the credit quality of its tenants (and more specifically the tenants’ ability to pay their rent obligations to the Company) is the tenants’ lease coverage ratios. These coverage ratios include earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) to rent coverage and earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent coverage at the facility level and consolidated EBITDAR to total fixed charge coverage at the parent guarantor level when such a guarantee exists. The Company obtains various financial and operational information from its tenants each month and reviews this information in conjunction with the above-described coverage metrics to determine trends and the operational and financial impact of the environment in the industry (including the impact of government reimbursement) and the management of the tenant’s operations. These metrics help the Company identify potential areas of concern relative to its tenants’ credit quality and ultimately the tenants’ ability to generate sufficient liquidity to meet its obligations, including its obligation to continue to pay the rent due to the Company.
	As of September 30, 2014, the future minimum rental payments from the Company’s properties under non-cancelable operating leases were as follows (in thousands):
	October 1, 2014 through December 31, 2014	$	41,907
	2015	171,645
	2016	175,883
	2017	180,825
	2018	185,817
	Thereafter	1,410,600
		$	2,166,677

LOANS_RECEIVABLE_AND_OTHER_INV

LOANS RECEIVABLE AND OTHER INVESTMENTS (Notes)	9 Months Ended
	Sep. 30, 2014
Loans Receivable and Other Investments [Abstract]	'
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	'
	LOANS RECEIVABLE AND OTHER INVESTMENTS
	As of September 30, 2014, the Company’s loans receivable and other investments consisted of the following (dollars in thousands):
	Investment	Quantity	Facility Type	Principal Balance as of September 30, 2014		Book Value as of September 30, 2014		Weighted Average Contractual Rate		Weighted Average Annualized Effective Rate		Maturity Date
	Loans Receivable:
	Mortgage	4	Skilled Nursing / Senior Housing / Acute Care Hospital	$	150,112	$	150,515	8.2	%	8.1	%	10/31/16 - 1/31/18
	Construction	3	Acute Care Hospital / Memory Care	62,541		62,845		7.5	%	7.3	%	9/30/16 - 10/31/18
	Mezzanine	2	Skilled Nursing / Senior Housing	21,730		21,797		11.3	%	11.1	%	12/27/14 - 08/31/17
	Pre-development	5	Senior Housing	3,572		3,696		9	%	8.2	%	8/16/15 - 09/09/17
		14		237,955		238,853		8.3	%	8.2	%
	Other Investments:
	Preferred Equity	4	Senior Housing	11,631		11,821		11.9	%	11.9	%	NA
	Total	18		$	249,586	$	250,674	8.5	%	8.4	%
	Meridian Mezzanine Loan
	On August 15, 2014, the Company originated a $15.5 million mezzanine loan (the “Meridian Mezzanine Loan”) with affiliates of Meridian ALZ Investors, LLC (“Meridian”) in connection with the Company’s previously announced pipeline agreement with Meridian. The proceeds of the mezzanine loan were used to repay the Company's existing preferred equity investment in an affiliate of Meridian totaling $8.3 million (including accrued and unpaid preferred returns), resulting in a net investment by the Company of $7.2 million. The Meridian Mezzanine Loan has a three-year term and bears interest at a fixed rate of 11.0% per annum. It is secured by Meridian's equity interest in two memory care facilities and a skilled nursing facility.
	Chai Acquisition Option Exercise
	On March 5, 2014, the Company exercised its option to purchase two skilled nursing facilities indirectly securing a related mezzanine loan for $24.5 million.
	At the closing of the acquisition, $5.8 million of the sales proceeds were used to repay a portion of the mezzanine loan, resulting in the Company funding an additional $18.7 million for the acquisition and leaving $6.5 million outstanding under the mezzanine loan. The Company continues to have an option to purchase up to an additional $25.5 million of the remaining ten properties securing the mezzanine loan.

DEBT

DEBT	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Debt	'
		DEBT
	Mortgage Indebtedness
	The Company’s mortgage notes payable consisted of the following (dollars in thousands):
	Interest Rate Type	Book Value as of			Book Value as of			Weighted Average			Maturity
		30-Sep-14			December 31, 2013			Effective Interest Rate at			Date
								30-Sep-14
	Fixed Rate	$	124,714		$	54,688		3.96	%		May 2031 - August 2051
	Variable Rate	—			86,640			NA			NA
		$	124,714		$	141,328		3.96	%
	Mortgage Debt Refinancing. On January 21, 2014, the Company refinanced $44.8 million of existing variable rate mortgage indebtedness due August 2015 with mortgages guaranteed by the United States Department of Housing and Urban Development (“HUD”) at an interest rate of 4.25% with maturities between 2039 and 2044. In addition, on April 8, 2014, the Company refinanced of $11.6 million of variable rate mortgage indebtedness that was previously repaid with funds from its Revolving Credit Facility (defined below). This new $11.6 million mortgage loan is guaranteed by HUD, has an interest rate of 4.10% and matures in 2044. In connection with these refinancings, the Company wrote off $0.5 million in unamortized deferred financing costs during the nine months ended September 30, 2014 and included this amount in loss on extinguishment of debt on the accompanying condensed consolidated statements of income.
	Mortgage Debt Repayment. On May 1, 2014, the Company repaid $29.8 million of existing variable rate mortgage indebtedness, having an interest rate of 5.0% per annum, with proceeds from its Revolving Credit Facility. In connection with this repayment, the Company wrote off $0.1 million in unamortized deferred financing costs during the nine months ended September 30, 2014 and included this amount in loss on extinguishment of debt on the accompanying condensed consolidated statements of income.
	Senior Unsecured Notes
	5.5% Notes due 2021. On January 23, 2014, the Operating Partnership and Sabra Capital Corporation, wholly owned subsidiaries of the Company (the “Issuers”), completed an underwritten public offering of $350.0 million aggregate principal amount of 5.5% senior unsecured notes (the “2021 Notes”). The 2021 Notes were sold at par, resulting in gross proceeds of $350.0 million and net proceeds of approximately $340.8 million after deducting underwriting discounts and other offering expenses. The 2021 Notes accrue interest at a rate of 5.5% per annum payable semiannually on February 1 and August 1 of each year.
	On October 10, 2014, the Issuers issued an additional $150.0 million aggregate principal amount of 2021 Notes, which are treated as a single class with, and have the same terms as, the existing 2021 Notes. The notes were issued at 99.5% providing net proceeds of approximately $145.8 million (not including pre-issuance accrued interest), after deducting underwriting discounts and other offering expenses and a yield-to-maturity of 5.593%. The Company used the proceeds from this offering to repay borrowings outstanding under the Revolving Credit Facility.
	The 2021 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after February 1, 2017, at the redemption prices set forth in the supplemental indenture governing the 2021 Notes (the “2021 Notes Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to February 1, 2017, the Issuers may redeem all or a portion of the 2021 Notes at a redemption price equal to 100% of the principal amount of the 2021 Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to February 1, 2017, the Issuers may redeem up to 35% of the principal amount of the 2021 Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 105.5% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the 2021 Notes are not redeemed, the 2021 Notes mature on February 1, 2021.
	5.375% Notes Due 2023. On May 23, 2013, the Issuers completed an underwritten public offering of $200.0 million aggregate principal amount of 5.375% senior unsecured notes (the “2023 Notes”). The 2023 Notes were sold at par, resulting in gross proceeds of $200.0 million and net proceeds of approximately $194.6 million after deducting underwriting discounts and other offering expenses. The 2023 Notes accrue interest at a rate of 5.375% per annum payable semiannually on June 1 and December 1 of each year.
	The 2023 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after June 1, 2018, at the redemption prices set forth in the supplemental indenture governing the 2023 Notes (the “2023 Notes Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to June 1, 2018, the Issuers may redeem all or a portion of the 2023 Notes at a redemption price equal to 100% of the principal amount of the 2023 Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to June 1, 2016, the Issuers may redeem up to 35% of the principal amount of the 2023 Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 105.375% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the 2023 Notes are not redeemed, the 2023 Notes mature on June 1, 2023.
	8.125% Notes due 2018. On October 27, 2010 and July 26, 2012, the Issuers issued $225.0 million and $100.0 million aggregate principal amount of 8.125% senior unsecured notes (the “2018 Notes”), respectively. Pursuant to exchange offers completed on March 14, 2011 and November 14, 2012, the Issuers exchanged the 2018 Notes that were issued in October 2010 and July 2012 for substantially identical 2018 Notes registered under the Securities Act of 1933, as amended. The 2018 Notes accrued interest at a rate of 8.125% per annum payable semiannually on May 1 and November 1 of each year.
	On June 24, 2013, pursuant to the terms of the indenture governing the 2018 Notes (the “2018 Notes Indenture”), the Issuers redeemed $113.8 million in aggregate principal amount of the then-outstanding 2018 Notes, representing 35% of the aggregate principal amount of the 2018 Notes outstanding. The 2018 Notes were redeemed at a redemption price of 108.125% of the principal amount redeemed, plus accrued and unpaid interest up to the redemption date. The redemption resulted in a $9.8 million loss on extinguishment of debt, including $9.3 million in payments made to noteholders for early redemption and $0.5 million of write-offs associated with unamortized deferred financing costs and issuance premium.
	On January 8, 2014, the Company commenced a cash tender offer with respect to any and all of the outstanding $211.3 million of the 2018 Notes. Pursuant to the tender offer, the Company retired $210.9 million of the 2018 Notes at a premium of 109.837%, plus accrued and unpaid interest, on January 23, 2014. Pursuant to the terms of the 2018 Notes Indenture, the remaining $0.4 million of the 2018 Notes were called and were retired on February 11, 2014 at a redemption price of 109.485% plus accrued and unpaid interest. The tender offer and redemption resulted in $21.6 million of tender offer and redemption related costs and write-offs for the nine months ended September 30, 2014, including $20.8 million in payments made to noteholders for early redemption and $0.8 million of write-offs associated with unamortized deferred financing and premium costs. These amounts are included in loss on extinguishment of debt on the accompanying condensed consolidated statements of income.
	The obligations under the 2021 Notes and 2023 Notes (collectively, the “Senior Notes”) are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and certain of Sabra’s other existing and, subject to certain exceptions, future material subsidiaries; provided, however, that such guarantees are subject to release under certain customary circumstances.  See Note 10, “Summarized Condensed Consolidating Information” for additional information concerning the circumstances pursuant to which the guarantors will be automatically and unconditionally released from their obligations under the guarantees.
	The indentures governing the Senior Notes (the “Senior Notes Indentures”) contain restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Sabra’s restricted subsidiaries to pay dividends or other amounts to Sabra. Such limitations on distributions also include a limitation on the extent of allowable cumulative distributions made not to exceed the greater of (a) the sum of (x) 95% of cumulative Adjusted Funds from Operations and (y) the net proceeds from the issuance of common and preferred equity and (b) the minimum amount of distributions required for the Company to maintain its REIT status. The Senior Notes Indentures also provide for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Senior Notes, the failure to comply with certain covenants and agreements specified in the Senior Notes Indentures for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding Senior Notes may become due and payable immediately. The Company was in compliance with all applicable financial covenants under the Senior Notes Indentures related to the Senior Notes outstanding as of September 30, 2014.
	Revolving Credit Facility
	On September 10, 2014, the Operating Partnership entered into a second amended and restated unsecured revolving credit facility (the “Revolving Credit Facility”) with certain lenders as set forth in the related credit agreement and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer (each as defined in such credit agreement). The Revolving Credit Facility amends and restates the amended and restated secured revolving credit facility (the “Prior Revolving Credit Facility”) that the Operating Partnership and certain subsidiaries of the Operating Partnership entered into on July 29, 2013 and amended on October 15, 2013.
	The Revolving Credit Facility provides for a borrowing capacity of $650.0 million and provides an accordion feature allowing for an additional $100.0 million of capacity, subject to terms and conditions, resulting in a maximum borrowing capacity of $750.0 million. The Operating Partnership also has an option to convert up to $200.0 million of the Revolving Credit Facility to a term loan subject to terms and conditions. On October 10, 2014, the Operating Partnership converted $200.0 million of the outstanding borrowings under the Revolving Credit Facility to a term loan. Concurrent with the term loan conversion, the Company entered into a five-year interest rate cap contract that caps LIBOR at 2.0%.
	While the Prior Revolving Credit Facility was secured by pledges of equity by the Company’s wholly-owned subsidiaries that own certain of the Company's real estate assets, the Revolving Credit Facility is unsecured. The Revolving Credit Facility, including amounts that are converted into a term loan, has a maturity date of September 10, 2018, and includes a one year extension option. As of September 30, 2014, there was $614.0 million outstanding under the Company’s Revolving Credit Facility.
	In connection with the Revolving Credit Facility, the Company wrote off $0.2 million of unamortized deferred financing costs during the nine months ended September 30, 2014. These amounts are included in loss on extinguishment of debt on the accompanying condensed consolidated statements of income.
	Borrowings under the Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Operating Partnership's option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (referred to as the “Base Rate”). The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the Revolving Credit Facility, and will range from 2.00% to 2.60% per annum for LIBOR based borrowings and 1.00% to 1.60% per annum for borrowings at the Base Rate. As of September 30, 2014, the interest rate on the Revolving Credit Facility was 2.46%. In addition, the Operating Partnership is required to pay an unused fee to the lenders equal to 0.25% or 0.35% per annum based on the amount of unused borrowings under the Revolving Credit Facility. During the three and nine months ended September 30, 2014, the Company incurred $0.3 million and $2.3 million, respectively, in interest expense on amounts outstanding under the Revolving Credit Facility. During the three and nine months ended September 30, 2014, the Company incurred $0.5 million and $1.1 million, respectively, of unused facility fees.
	In the event that Sabra achieves at least two investment grade ratings from S&P, Moody’s and/or Fitch, the Operating Partnership can elect to reduce the applicable percentage for LIBOR or Base Rate borrowings. If the Operating Partnership makes this election, the applicable percentage for borrowings will vary based on the Debt Ratings at each Pricing Level, as defined in the credit agreement, and will range from 0.90% to 1.70% per annum for LIBOR based borrowings and 0.00% to 0.70% per annum for borrowings at the Base Rate. In addition, should the Operating Partnership elect this option, the unused fee will no longer apply and a facility fee ranging between 0.125% and 0.300% per annum will take effect based on the borrowing capacity regardless of amounts outstanding under the Revolving Credit Facility.
	The obligations of the Operating Partnership under the Revolving Credit Facility are guaranteed by Sabra and certain subsidiaries of Sabra.
	The Revolving Credit Facility contains customary covenants that include restrictions or limitations on the ability to make acquisitions and other investments, make distributions, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Revolving Credit Facility also requires Sabra, through the Operating Partnership, to comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of September 30, 2014, the Company was in compliance with all applicable financial covenants under the Revolving Credit Facility.
	Interest Expense
	The Company incurred interest expense of $10.5 million and $32.7 million during the three and nine months ended September 30, 2014, respectively, and $9.7 million and $29.9 million during the three and nine months ended September 30, 2013, respectively. Interest expense includes deferred financing costs amortization of $0.9 million and $2.8 million for the three and nine months ended September 30, 2014, respectively, and $0.8 million and $2.4 million for the three and nine months ended September 30, 2013, respectively. As of September 30, 2014 and December 31, 2013, the Company had $7.9 million and $4.7 million, respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying condensed consolidated balance sheets.
	Maturities
	The following is a schedule of maturities for the Company’s outstanding debt as of September 30, 2014 (in thousands):
			Mortgage			Senior Notes			Revolving Credit Facility (1) (2)			Total
			Indebtedness
	October 1, 2014 through December 31, 2014		$	691		$	—		$	—		$	691
	2015		2,823			—			—			2,823
	2016		2,917			—			—			2,917
	2017		3,013			—			—			3,013
	2018		3,114			—			614,000			617,114
	Thereafter		112,156			550,000			—			662,156
			$	124,714		$	550,000		$	614,000		$	1,288,714
	(1) Subject to a one-year extension option.
	(2) On October 10, 2014, the Operating Partnership converted $200.0 million of the outstanding borrowings under the Revolving Credit Facility to a term loan.

FAIR_VALUE_DISCLOSURES

FAIR VALUE DISCLOSURES	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures	'
	FAIR VALUE DISCLOSURES
	The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments.
	Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, the Revolving Credit Facility, accounts payable and accrued liabilities are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows:
	Loans receivable: These instruments are presented in the accompanying condensed consolidated balance sheets at their amortized cost and not at fair value. The fair value of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, the underlying collateral value and other credit enhancements.
	Preferred equity investments: These instruments are presented in the accompanying condensed consolidated balance sheets at their cost and not at fair value. The fair value of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investment, the underlying collateral value and other credit enhancements.
	Senior Notes: The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades.
	Mortgage indebtedness: The fair values of the Company’s mortgage notes payable were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements.
	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of September 30, 2014 and December 31, 2013 whose carrying amounts do not approximate their fair value (in thousands):
		September 30, 2014								December 31, 2013
		Face				Carrying		Fair		Face		Carrying		Fair
		Value (1)				Amount (2)		Value		Value (1)		Amount (2)		Value
	Financial assets:
	Loans receivable	$	237,955			$	238,853	$	237,385	$	176,558	$	177,509	$	176,985
	Preferred equity investments	11,631				11,821		12,268		7,695		7,784		7,950
	Financial liabilities:
	Senior Notes	550,000				550,000		547,000		411,250		414,402		421,122
	Mortgage indebtedness	124,714				124,714		108,467		141,328		141,328		130,622
	(1) Face value represents amounts contractually due under the terms of the respective agreements.
	(2) Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).
	The Company determined the fair value of financial instruments as of September 30, 2014 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):
						Fair Value Measurements Using
						Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
		Total				(Level 1)		(Level 2)		(Level 3)
	Financial assets:
	Loans receivable	$	237,385			$	—	$	—	$	237,385
	Preferred equity investments	12,268				—		—		12,268
	Financial liabilities:
	Senior Notes	547,000				—		547,000		—
	Mortgage indebtedness	108,467				—		—		108,467
	Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Despite increased capital market and credit market activity, transaction volume for certain financial instruments remains relatively low. This has made the estimation of fair values difficult and, therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different.
	During the nine months ended September 30, 2014, the Company recorded the following amounts measured at fair value (in thousands):
						Fair Value Measurements Using
						Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
		Total				(Level 1)		(Level 2)		(Level 3)
	Recurring Basis:
	Contingent consideration liability	$	4,600			$	—	$	—	$	4,600
	The Company’s contingent consideration liability is the result of two acquisitions of real estate properties (see Note 3, “Recent Real Estate Acquisitions” for further details regarding the new contingent liability). In order to determine the fair value of the Company’s contingent consideration liability, the Company used significant inputs not observable in the market to estimate the liability, then developed probability-weighted scenarios of the potential future performance of the tenant and the resulting payout from these scenarios. As of September 30, 2014, the total contingent consideration liability was valued at $4.6 million. The following reconciliation provides the details of activity during the nine months ended September 30, 2014 for contingent consideration liability recorded at fair value using Level 3 inputs:
	Balance as of December 31, 2013		$	7,500
	New contingent liability		3,200
	Decrease in contingent liability		(860		)
	Payment of contingent liability		(5,240		)
	Balance as of September 30, 2014		$	4,600
	A corresponding amount equal to the decrease in contingent liability was included as other income on the accompanying condensed consolidated statements of income for the three and nine months ended September 30, 2014.

EQUITY

EQUITY	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Equity	'
	EQUITY
	Preferred Stock
	On March 21, 2013, the Company completed an underwritten public offering of 5.8 million shares of 7.125% Series A Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") at a price of $25.00 per share, pursuant to an effective registration statement. The Company received net proceeds of $138.3 million from the offering, after deducting underwriting discounts and other offering expenses. The Company classified the par value as preferred equity on its condensed consolidated balance sheets with the balance of the liquidation preference, net of any issuance costs, recorded as an increase in paid-in capital.
	The holders of the Company’s Series A Preferred Stock rank senior to the Company’s common stock with respect to dividend rights and rights upon the Company’s liquidation, dissolution or winding up of its affairs. At September 30, 2014, there were no dividends in arrears.
	The Series A Preferred Stock does not have a stated maturity date, but the Company may redeem the Series A Preferred Stock on or after March 21, 2018, for $25.00 per share, plus any accrued and unpaid dividends.  The Company may redeem the Series A Preferred Stock prior to March 21, 2018, in limited circumstances to preserve its status as a REIT or pursuant to a specified change of control.  Upon the occurrence of a specified change of control, each holder of Series A Preferred Stock will have the right to convert some or all of the shares of Series A Preferred Stock held by such holder into a number of shares of the Company’s common stock equivalent to $25.00 plus accrued and unpaid dividends, but not to exceed a cap of 1.7864 shares of common stock per share of Series A Preferred Stock (subject to certain adjustments).
	Common Stock
	The following table lists the cash dividends on common stock declared and paid by the Company during the nine months ended September 30, 2014:
	Declaration Date	Record Date	Amount Per Share		Dividend Payable Date
	23-Jan-14	15-Feb-14	$	0.36	28-Feb-14
	5-May-14	15-May-14	0.38		30-May-14
	30-Jul-14	15-Aug-14	0.38		29-Aug-14
	On May 12, 2014, the Company completed an underwritten public offering of 8.1 million newly issued shares of its common stock pursuant to an effective registration statement.  The Company received net proceeds, before expenses, of $219.1 million from the offering, after giving effect to the issuance and sale of all 8.1 million shares of common stock (which included 1.1 million shares sold to the underwriters upon exercise of their option to purchase additional shares), at a price to the public of $28.35 per share.
	On October 3, 2014, the Company completed an underwritten public offering of 6.9 million newly issued shares of its common stock pursuant to an effective registration statement.  The Company received net proceeds, before expenses, of $160.6 million from the offering, after giving effect to the issuance and sale of all 6.9 million shares of common stock (which included 0.9 million shares sold to the underwriters upon exercise of their option to purchase additional shares), at a price to the public of $24.25 per share.
	During the nine months ended September 30, 2014, the Company issued 0.2 million shares of common stock as a result of restricted stock unit vestings and in connection with amounts payable under the Company's 2013 Bonus Plan pursuant to an election by certain participants to receive their bonus payment in shares of the Company's common stock. During the nine months ended September 30, 2014, the Company issued 11,515 shares of common stock as a result of stock options exercised.
	Upon any payment of shares as a result of restricted stock unit vestings, the participant is required to satisfy the related tax withholding obligation. The 2009 Performance Incentive Plan provides that the Company has the right at its option to (a) require the participant to pay such tax withholding or (b) reduce the number of shares to be delivered by a number of shares necessary to satisfy the related minimum applicable statutory tax withholding obligation. During the nine months ended September 30, 2014, pursuant to advance elections made by certain participants, the Company paid $5.1 million in tax withholding obligations that were satisfied through a reduction in the number of shares delivered to those participants.
	At-The-Market Common Stock Offering Program (“ATM Program”)
	On March 18, 2013, the Company entered into a sales agreement (each, a “Sales Agreement”) with each of Barclays Capital Inc., Cantor Fitzgerald & Co., Credit Agricole Securities (USA) Inc., RBC Capital Markets, LLC, RBS Securities Inc. and Wells Fargo Securities, LLC (individually, a “Sales Agent” and together, the “Sales Agents”) to sell shares of its common stock having aggregate gross proceeds of up to $100.0 million (the “ATM Shares”) from time to time through the Sales Agents.
	Pursuant to the terms of the Sales Agreements, the ATM Shares may be sold by any method permitted by law deemed to be an “at-the-market” offering, including, without limitation, sales made directly on the NASDAQ Global Select Market, on any other existing trading market for the Company's common stock or to or through a market maker. In addition, with the Company's prior consent, the Sales Agents may also sell the ATM Shares in privately negotiated transactions. The Company will pay each Sales Agent a commission of up to 2% of the gross proceeds from the sales of ATM Shares sold pursuant to the applicable Sales Agreement.
	During the three months ended September 30, 2014, the Company sold 0.4 million ATM Shares, at an average price of $28.28 per share, generating gross proceeds of approximately $10.3 million, before $0.2 million of commissions. During the nine months ended September 30, 2014, the Company sold 0.6 million ATM Shares, at an average price of $28.05 per share, generating gross proceeds of approximately $16.9 million, before $0.3 million of commissions. As of September 30, 2014, the Company had $44.8 million available under the ATM Program.

EARNINGS_PER_COMMON_SHARE

EARNINGS PER COMMON SHARE	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Common Share	'
	EARNINGS PER COMMON SHARE
	The following table illustrates the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2014 and 2013 (in thousands, except share and per share amounts):
		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
	Numerator
	Net income attributable to common stockholders	$	14,643	$	9,242	$	17,020	$	15,310
	Denominator
	Basic weighted average common shares	47,359,949		37,358,334		43,358,620		37,334,120
	Dilutive stock options and restricted stock units	517,253		470,239		481,930		443,338
	Diluted weighted average common shares	47,877,202		37,828,573		43,840,550		37,777,458
	Net income attributable to common stockholders, per:
	Basic common share	$	0.31	$	0.25	$	0.39	$	0.41
	Diluted common share	$	0.31	$	0.24	$	0.39	$	0.41
	Certain of our outstanding restricted stock units are considered participating securities because dividend payments are not forfeited even if the underlying award does not vest. Accordingly, the Company uses the two-class method when computing basic and diluted earnings per share. During the three months ended September 30, 2014 and 2013, no restricted stock units were considered anti-dilutive. During the nine months ended September 30, 2014, approximately 5,000 restricted stock units were not included because they were considered anti-dilutive. During the nine months ended September 30, 2013, approximately 3,000 restricted stock units were not included because they were anti-dilutive. No stock options were considered anti-dilutive during the three and nine months ended September 30, 2014 and 2013.

SUMMARIZED_CONDENSED_CONSOLIDA

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION	9 Months Ended
	Sep. 30, 2014
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]	'
Summarized Condensed Consolidating Information	'
	SUMMARIZED CONDENSED CONSOLIDATING INFORMATION
	In connection with the offerings of the Senior Notes by the Issuers and the Issuers’ previous offerings of the 2018 Notes (which were no longer outstanding as of September 30, 2014), the Company and certain 100% owned subsidiaries of the Company (the “Guarantors”) have, jointly and severally, fully and unconditionally guaranteed the Senior Notes, subject to release under certain customary circumstances as described below. These guarantees are subordinated to all existing and future senior debt and senior guarantees of the Guarantors and are unsecured. The Company conducts all of its business through and derives virtually all of its income from its subsidiaries. Therefore, the Company’s ability to make required payments with respect to its indebtedness (including the Senior Notes) and other obligations depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries.
	A Guarantor will be automatically and unconditionally released from its obligations under the guarantees with respect to the Senior Notes in the event of:
	•	Any sale of the subsidiary Guarantor or of all or substantially all of its assets;
	•	A merger or consolidation of a subsidiary Guarantor with an issuer of the Senior Notes or another Guarantor, provided that the surviving entity remains a Guarantor;
	•	A subsidiary Guarantor is declared “unrestricted” for covenant purposes under the Senior Notes Indentures;
	•	The requirements for legal defeasance or covenant defeasance or to discharge the Senior Notes Indentures have been satisfied;
	•	A liquidation or dissolution, to the extent permitted under the Senior Notes Indentures, of a subsidiary Guarantor; and
	•	The release or discharge of the guaranty that resulted in the creation of the subsidiary guaranty, except a discharge or release by or as a result of payment under such guaranty.
	Pursuant to Rule 3-10 of Regulation S-X, the following summarized condensed consolidating information is provided for the Company (the “Parent Company”), the Issuers, the Guarantors, and the Company’s non-Guarantor subsidiaries with respect to the Senior Notes. This summarized financial information has been prepared from the books and records maintained by the Company, the Issuers, the Guarantors and the non-Guarantor subsidiaries. The summarized financial information may not necessarily be indicative of the results of operations or financial position had the Issuers, the Guarantors or non-Guarantor subsidiaries operated as independent entities. Sabra’s investments in its consolidated subsidiaries are presented based upon Sabra's proportionate share of each subsidiary's net assets. The Guarantor subsidiaries’ investments in the non-Guarantor subsidiaries and non-Guarantor subsidiaries’ investments in Guarantor subsidiaries are presented under the equity method of accounting. Intercompany activities between subsidiaries and the Parent Company are presented within operating activities on the condensed consolidating statement of cash flows.
	Condensed consolidating financial statements for the Company and its subsidiaries, including the Parent Company only, the Issuers, the combined Guarantor subsidiaries and the combined non-Guarantor subsidiaries, are as follows:
	CONDENSED CONSOLIDATING BALANCE SHEET
	September 30, 2014
	(in thousands)
	(unaudited)
		Parent				Issuers				Combined				Combined Non-				Elimination				Consolidated
		Company								Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	63			$	—			$	1,426,998			$	141,207			$	—			$	1,568,268
	Loans receivable and other investments, net	—				—				250,674				—				—				250,674
	Cash and cash equivalents	21,475				—				—				4,004				—				25,479
	Restricted cash	—				—				160				6,377				—				6,537
	Deferred tax assets	24,212				—				—				—				—				24,212
	Prepaid expenses, deferred financing costs and other assets	977				20,920				112,615				7,684				—				142,196
	Intercompany	230,614				965,828				—				—				(1,196,442		)		—
	Investment in subsidiaries	417,157				602,179				24,887				—				(1,044,223		)		—
	Total assets	$	694,498			$	1,588,927			$	1,815,334			$	159,272			$	(2,240,665	)		$	2,017,366
	Liabilities
	Mortgage notes	$	—			$	—			$	—			$	124,714			$	—			$	124,714
	Revolving credit facility	—				614,000				—				—				—				614,000
	Senior unsecured notes	—				550,000				—				—				—				550,000
	Accounts payable and accrued liabilities	6,536				7,770				24,864				1,549				—				40,719
	Tax liability	24,212				—				—				—				—				24,212
	Intercompany	—				—				1,191,119				5,323				(1,196,442		)		—
	Total liabilities	30,748				1,171,770				1,215,983				131,586				(1,196,442		)		1,353,645
	Total equity	663,750				417,157				599,351				27,686				(1,044,223		)		663,721
	Total liabilities and equity	$	694,498			$	1,588,927			$	1,815,334			$	159,272			$	(2,240,665	)		$	2,017,366
	CONDENSED CONSOLIDATING BALANCE SHEET
	December 31, 2013
	(in thousands)
		Parent				Issuers				Combined				Combined  Non-				Elimination				Consolidated
		Company								Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	101			$	—			$	751,771			$	163,546			$	—			$	915,418
	Loans receivable and other investments, net	—				—				185,293				—				—				185,293
	Cash and cash equivalents	3,551				—				—				757				—				4,308
	Restricted cash	—				—				121				5,231				—				5,352
	Deferred tax assets	24,212				—				—				—				—				24,212
	Prepaid expenses, deferred financing costs and other assets	1,217				9,207				46,694				6,134				—				63,252
	Intercompany	63,125				270,194				—				42,637				(375,956		)		—
	Investment in subsidiaries	398,640				537,505				25,205				—				(961,350		)		—
	Total assets	$	490,846			$	816,906			$	1,009,084			$	218,305			$	(1,337,306	)		$	1,197,835
	Liabilities
	Mortgage notes	$	—			$	—			$	—			$	141,328			$	—			$	141,328
	Secured revolving credit facility	—				—				135,500				—				—				135,500
	Senior unsecured notes	—				414,402				—				—				—				414,402
	Accounts payable and accrued liabilities	6,470				3,864				11,008				887				—				22,229
	Tax liability	24,212				—				—				—				—				24,212
	Intercompany	—				—				375,956				—				(375,956		)		—
	Total liabilities	30,682				418,266				522,464				142,215				(375,956		)		737,671
	Total equity	460,164				398,640				486,620				76,090				(961,350		)		460,164
Total liabilities and equity	$	490,846			$	816,906			$	1,009,084			$	218,305			$	(1,337,306	)		$	1,197,835
CONDENSED CONSOLIDATING STATEMENT OF INCOME
For the Three Months Ended September 30, 2014
(dollars in thousands, except per share amounts)
(unaudited)
	Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Revenues:
Rental income	$	—			$	—			$	33,290			$	4,875			$	—			$	38,165
Interest and other income	2				—				5,141				676				—				5,819
Total revenues	2				—				38,431				5,551				—				43,984
Expenses:
Depreciation and amortization	13				—				8,288				1,461				—				9,762
Interest	—				8,435				749				1,356				—				10,540
General and administrative	3,573				—				2,133				520				—				6,226
Total expenses	3,586				8,435				11,170				3,337				—				26,528
Other (expense) income:
Loss on extinguishment of debt	—				—				(158		)		—				—				(158		)
Other income (expense)	—				—				(100		)		—				—				(100		)
Total other (expense) income	—				—				(258		)		—				—				(258		)
Income in subsidiary	20,788				29,223				1,304				—				(51,315		)		—
Net income	17,204				20,788				28,307				2,214				(51,315		)		17,198
Net loss attributable to noncontrolling interests	—				—				—				6				—				6
Net income attributable to Sabra Health Care REIT, Inc.	17,204				20,788				28,307				2,220				(51,315		)		17,204
Preferred stock dividends	(2,561		)		—				—				—				—				(2,561		)
Net income attributable to common stockholders	$	14,643			$	20,788			$	28,307			$	2,220			$	(51,315	)		$	14,643
Net income attributable to common stockholders, per:
Basic common share																					$	0.31
Diluted common share																					$	0.31
Weighted-average number of common shares outstanding, basic																					47,359,949
Weighted-average number of common shares outstanding, diluted																					47,877,202
CONDENSED CONSOLIDATING STATEMENT OF INCOME
For the Three Months Ended September 30, 2013
(dollars in thousands, except per share amounts)
(unaudited)
	Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Revenues:
Rental income	$	—			$	—			$	24,380			$	7,319			$	—			$	31,699
Interest and other income	13				—				1,214				—				—				1,227
Total revenues	13				—				25,594				7,319				—				32,926
Expenses:
Depreciation and amortization	13				—				6,365				1,880				—				8,258
Interest	—				7,147				817				1,775				—				9,739
General and administrative	2,996				—				41				20				—				3,057
Total expenses	3,009				7,147				7,223				3,675				—				21,054
Other (expense) income:
Loss on extinguishment of debt	—				—				(351		)		—				—				(351		)
Other income (expense)	—				—				300				—				—				300
Total other (expense) income	—				—				(51		)		—				—				(51		)
Income in subsidiary	14,817				21,964				982				—				(37,763		)		—
Net income	11,821				14,817				19,302				3,644				(37,763		)		11,821
Preferred dividends	(2,579		)		—				—				—				—				(2,579		)
Net income attributable to common stockholders	$	9,242			$	14,817			$	19,302			$	3,644			$	(37,763	)		$	9,242
Net loss attributable to common stockholders, per:
Basic common share																					$	0.25
Diluted common share																					$	0.24
Weighted-average number of common shares outstanding, basic																					37,358,334
Weighted-average number of common shares outstanding, diluted																					37,828,573
CONDENSED CONSOLIDATING STATEMENT OF INCOME
For the Nine Months Ended September 30, 2014
(dollars in thousands, except per share amounts)
(unaudited)
	Parent Company					Issuers				Combined					Combined Non-				Elimination				Consolidated
										Guarantor					Guarantor
										Subsidiaries					Subsidiaries
Revenues:
Rental income	$	—				$	—			$	97,384				$	14,359			$	—			$	111,743
Interest and other income	9					—				14,039					2,016				—				16,064
Total revenues	9					—				111,423					16,375				—				127,807
Expenses:
Depreciation and amortization	38					—				24,642					4,187				—				28,867
Interest	—					24,189				4,642					3,837				—				32,668
General and administrative	12,133					2				6,142					1,728				—				20,005
Total expenses	12,171					24,191				35,426					9,752				—				81,540
Other (expense) income:
Loss on extinguishment of debt	—					(21,846		)		(472		)			(136		)		—				(22,454		)
Other income (expense)	—					—				860					—				—				860
Total other (expense) income	—					(21,846		)		388					(136		)		—				(21,594		)
Income in subsidiary	36,864					82,901				4,368					—				(124,133		)		—
Net income	24,702					36,864				80,753					6,487				(124,133		)		24,673
Net loss attributable to noncontrolling interests	—					—				—					29				—				29
Net income attributable to Sabra Health Care REIT, Inc.	24,702					36,864				80,753					6,516				(124,133		)		24,702
Preferred dividends	(7,682		)			—				—					—				—				(7,682		)
Net income attributable to common stockholders	$	17,020		—		$	36,864			$	80,753		—		$	6,516			$	(124,133	)		$	17,020
Net income attributable to common stockholders, per:
Basic common share																							$	0.39
Diluted common share																							$	0.39
Weighted-average number of common shares outstanding, basic																							43,358,620
Weighted-average number of common shares outstanding, diluted																							43,840,550
CONDENSED CONSOLIDATING STATEMENT OF INCOME
For the Nine Months Ended September 30, 2013
(dollars in thousands, except per share amounts)
(unaudited)
	Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Revenues:
Rental income	$	—			$	—			$	72,733			$	21,959			$	—			$	94,692
Interest and other income	82				—				2,449				—				—				2,531
Total revenues	82				—				75,182				21,959				—				97,223
Expenses:
Depreciation and amortization	38				—				18,983				5,705				—				24,726
Interest	—				21,585				2,797				5,502				—				29,884
General and administrative	10,671				4				453				68				—				11,196
Total expenses	10,709				21,589				22,233				11,275				—				65,806
Other (expense) income:
Loss on extinguishment of debt	—				(9,750		)		(351		)		—				—				(10,101		)
Other income (expense)	—				—				(600		)		—				—				(600		)
Total other (expense) income	—				(9,750		)		(951		)		—				—				(10,701		)
Income in subsidiary	31,343				62,682				2,892				—				(96,917		)		—
Net income	20,716				31,343				54,890				10,684				(96,917		)		20,716
Preferred dividends	(5,406		)		—				—				—				—				(5,406		)
Net income attributable to common stockholders	$	15,310			$	31,343			$	54,890			$	10,684			$	(96,917	)		$	15,310
Net income attributable to common stockholders, per:
Basic common share																					$	0.41
Diluted common share																					$	0.41
Weighted-average number of common shares outstanding, basic																					37,334,120
Weighted-average number of common shares outstanding, diluted																					37,777,458
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Nine Months Ended September 30, 2014
(in thousands)
(unaudited)
	Parent Company				Issuers				Combined				Combined  Non-					Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Net cash (used in) provided by operating activities	$	40,289			$	—			$	—			$	30,950				$	—			$	71,239
Cash flows from investing activities:
Acquisitions of real estate	—				—				(713,778		)		(8,101		)			—				(721,879		)
Origination of loans receivable	—				—				(59,256		)		—					—				(59,256		)
Preferred equity investment	—				—				(11,300		)		—					—				(11,300		)
Additions to real estate	—				—				(1,128		)		(23		)			—				(1,151		)
Repayment of loans receivable	—				—				287				—					—				287
Investment in subsidiaries	(12,288		)		(12,288		)		—				—					24,576				—
Intercompany financing	(182,248		)		(915,786		)		—				—					1,098,034				—
Net cash used in investing activities	(194,536		)		(928,074		)		(785,175		)		(8,124		)			1,122,610				(793,299		)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes	—				350,000				—				—			—		—				350,000
Principal payments on senior unsecured notes	—				(211,250		)		—				—					—				(211,250		)
Proceeds from revolving credit facility	—				604,000				95,000				—					—				699,000
Payments on revolving credit facility	—				—				(220,500		)		—					—				(220,500		)
Proceeds from mortgage notes	—				—				—				57,703					—				57,703
Principal payments on mortgage notes	—				—				—				(88,419		)			—				(88,419		)
Payments of deferred financing costs	—				(9,212		)		(5,111		)		(1,151		)			—				(15,474		)
Issuance of common stock	229,825				—				—				—					—				229,825
Dividends paid on common and preferred stock	(57,654		)		—				—				—					—				(57,654		)
Contribution from Parent	—				12,288				—				12,288					(24,576		)		—
Intercompany financing	—				182,248				915,786				—					(1,098,034		)		—
Net cash provided by (used in) financing activities	172,171				928,074				785,175				(19,579		)			(1,122,610		)		743,231
Net increase in cash and cash equivalents	17,924				—				—				3,247					—				21,171
Cash and cash equivalents, beginning of period	3,551				—				—				757					—				4,308
Cash and cash equivalents, end of period	$	21,475			$	—			$	—			$	4,004				$	—			$	25,479
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Nine Months Ended September 30, 2013
(in thousands)
(unaudited)
	Parent Company				Issuers				Combined				Combined  Non-				Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Net cash provided by operating activities	$	36,878			$	—			$	—			$	12,333			$	—			$	49,211
Cash flows from investing activities:
Acquisitions of real estate	—				—				(6,175		)		—				—				(6,175		)
Origination of note receivable	—				—				(26,393		)		—				—				(26,393		)
Preferred equity investment	—				—				(6,624		)		—				—				(6,624		)
Additions to real estate	—				—				(388		)		—				—				(388		)
Net proceeds from the sale of real estate	—				—				—				2,208				—				2,208
Distribution from subsidiaries	3,345				3,345				—				—				(6,690		)		—
Intercompany financing	(52,041		)		(132,883		)		—				—				184,924				—
Net cash (used in) provided by investing activities	(48,696		)		(129,538		)		(39,580		)		2,208				178,234				(37,372		)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes	—				200,000				—				—				—				200,000
Principal payments on senior unsecured notes	—				(113,750		)		—				—				—				(113,750		)
Payments on secured revolving credit facility	—				—				(92,500		)		—				—				(92,500		)
Principal payments on mortgage notes	—				—				—				(10,081		)		—				(10,081		)
Payments of deferred financing costs	—				(5,408		)		(3,011		)		(179		)		—				(8,598		)
Issuance of common stock	(2,950		)		—				—				—				—				(2,950		)
Issuance of preferred stock	138,257				—				—				—				—				138,257
Dividends paid	(42,677		)		—				—				—				—				(42,677		)
Distribution to Parent	—				(3,345		)		—				(3,345		)		6,690				—
Intercompany financing	—				52,041				135,091				(2,208		)		(184,924		)		—
Net cash provided by (used in) financing activities	92,630				129,538				39,580				(15,813		)		(178,234		)		67,701
Net increase (decrease) in cash and cash equivalents	80,812				—				—				(1,272		)		—				79,540
Cash and cash equivalents, beginning of period	15,075				—				—				2,026				—				17,101
Cash and cash equivalents, end of period	$	95,887			$	—			$	—			$	754			$	—			$	96,641

PRO_FORMA_FINANCIAL_INFORMATIO

PRO FORMA FINANCIAL INFORMATION (Notes)	9 Months Ended
	Sep. 30, 2014
PRO FORMA FINANCIAL INFORMATION [Abstract]	'
Pro Forma Financial Information [Text Block]	'
	PRO FORMA FINANCIAL INFORMATION
	The following table summarizes, on an unaudited pro forma basis, the consolidated results of operations of the Company for the three and nine months ended September 30, 2014 and 2013. The Company acquired six skilled nursing facilities and 27 senior housing facilities during the nine months ended September 30, 2014. The following unaudited pro forma information has been prepared to give effect to these acquisitions as if these acquisitions occurred on January 1, 2013. This pro forma information does not purport to represent what the actual results of operations of the Company would have been had these acquisitions occurred on January 1, 2013, nor does it purport to predict the results of operations for future periods.
		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
		(in thousands, except share and per share amounts)
	Revenues	$	53,706	$	46,572	$	160,491	$	138,159
	Depreciation and amortization	13,483		13,004		40,573		38,933
	Net income attributable to common stockholders	22,456		16,328		40,221		39,818
	Net income attributable to common stockholders, per:
	Basic common share	$	0.47	$	0.44	$	0.93	$	1.07
	Diluted common share	$	0.47	$	0.43	$	0.92	$	1.05
	Weighted-average number of common shares outstanding, basic	47,359,949		37,358,334		43,358,620		37,334,120
	Weighted-average number of common shares outstanding, diluted	47,877,202		37,828,573		43,840,550		37,777,458

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosures [Text Block]	'
	COMMITMENTS AND CONTINGENCIES
	Environmental
	As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. Compliance with existing environmental laws is not expected to have a material adverse effect on the Company’s financial condition and results of operations as of September 30, 2014.
	Income Taxes
	As a result of the Company’s separation from Sun Healthcare Group, Inc. (“Sun”) effective November 15, 2010 (the “Separation Date”), the Company is the surviving taxpayer for income tax purposes. Accordingly, tax positions taken prior to the Separation Date remained the Company’s obligations after the Separation Date. Sun agreed to indemnify the Company against, among other things, federal, state and local taxes (including penalties and interest) related to periods prior to the Separation Date to the extent the deferred tax assets allocated to the Company are not sufficient and/or cannot be utilized to satisfy these taxes.
	Effective December 1, 2012, Sun was acquired by Genesis HealthCare LLC (“Genesis”). As a result of its acquisition of Sun, Genesis became successor to the obligations of Sun described above.
	Legal Matters
	From time to time, the Company is party to legal proceedings that arise in the ordinary course of its business, including claims made before the Separation Date. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company's results of operations, financial condition or cash flows.

SUBSEQUENT_EVENTS_Notes

SUBSEQUENT EVENTS (Notes)	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	SUBSEQUENT EVENTS
	The Company evaluates subsequent events up until the date the condensed consolidated financial statements are issued.
	Dividend Declaration
	On November 3, 2014, the Company announced that its board of directors declared a quarterly cash dividend of $0.39 per share of common stock. The dividend will be paid on November 26, 2014 to common stockholders of record as of the close of business on November 14, 2014.
	On November 3, 2014, the Company also announced that its board of directors declared a quarterly cash dividend of $0.4453125 per share of Series A Preferred Stock. The dividend will be paid on November 26, 2014 to preferred stockholders of record as of the close of business on November 14, 2014.
	Investments
	Subsequent to September 30, 2014, the Company invested $81.7 million in four skilled nursing/transitional care facilities, four senior housing facilities and one debt investment.
	Debt and Equity Offering
	See Note 6, “Debt” and Note 8, “Equity” for details regarding the Company's October 2014 offering of an additional $150.0 million aggregate principal amount of 2021 Notes and the Company's October 2014 equity offering.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recently Issued Accounting Standards Update
	In April 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU No. 2014-08”), which changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. The standard no longer precludes presentation as a discontinued operation if (i) there are operations and cash flows of the component that have not been eliminated from the reporting entity’s ongoing operations, or (ii) there is significant continuing involvement with a component after its disposal. ASU No. 2014-08 is effective for public entities for interim and annual periods beginning after December 15, 2014, and will be applied prospectively.  The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.
	In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to a customer at an amount reflecting the consideration it expects to receive in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. Additionally, this guidance requires improved disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance specifically notes that lease contracts with customers are a scope exception. ASU 2014-09 is effective for the first interim period within annual reporting periods beginning after December 15, 2016, and early adoption is not permitted. The Company is currently in the process of evaluating the impact the adoption of ASU 2014-09 will have on the Company’s financial position or results of operations.
	In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” ASU 2014-15 requires management to evaluate whether there are conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern, and to provide certain disclosures when it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued. ASU 2014-15 is effective for the annual period ended December 31, 2016 and for annual periods and interim periods thereafter with early adoption permitted. The adoption of ASU 2014-15 is not expected to materially impact the Company’s consolidated financial statements.

RECENT_REAL_ESTATE_ACQUISITION1

RECENT REAL ESTATE ACQUISITIONS (Tables)	9 Months Ended
	Sep. 30, 2014
RECENT REAL ESTATE ACQUISITIONS [Abstract]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	The consideration was allocated as follows (in thousands):
					Intangibles
	Land		Building and Improvements		Tenant Origination and Absorption Costs		Tenant Relationship		Total Consideration
	$	54,387	$	625,536	$	7,924	$	2,991	$	690,838

REAL_ESTATE_INVESTMENTS_Tables

REAL ESTATE INVESTMENTS (Tables)	9 Months Ended
	Sep. 30, 2014
Real Estate Investments, Net [Abstract]	'
Schedule of Real Estate Properties	'
	REAL ESTATE PROPERTIES HELD FOR INVESTMENT
	The Company’s real estate properties held for investment consisted of the following (dollars in thousands):
	As of September 30, 2014
	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Transitional Care		102		11,460			$	825,378	$	(151,842	)	$	673,536
	Senior Housing		50		4,818			746,130		(17,395		)	728,735
	Acute Care Hospitals		2		124			175,807		(9,873		)	165,934
			154		16,402			1,747,315		(179,110		)	1,568,205
	Corporate Level							254		(191		)	63
								$	1,747,569	$	(179,301	)	$	1,568,268
	As of December 31, 2013
	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Transitional Care		96		10,826			$	737,188	$	(132,068	)	$	605,120
	Senior Housing		23		1,518			153,247		(13,337		)	139,910
	Acute Care Hospitals		2		124			175,807		(5,520		)	170,287
			121		12,468			1,066,242		(150,925		)	915,317
	Corporate Level							254		(153		)	101
								$	1,066,496	$	(151,078	)	$	915,418
		September 30, 2014			December 31, 2013
	Building and improvements	$	1,476,202		$	879,926
	Furniture and equipment	80,977			50,567
	Land improvements	4,392			4,392
	Land	185,998			131,611
		1,747,569			1,066,496
	Accumulated depreciation	(179,301		)	(151,078		)
		$	1,568,268		$	915,418
Schedule of Future Minimum Rental Payments Receivable for Operating Leases	'
	As of September 30, 2014, the future minimum rental payments from the Company’s properties under non-cancelable operating leases were as follows (in thousands):
	October 1, 2014 through December 31, 2014	$	41,907
	2015	171,645
	2016	175,883
	2017	180,825
	2018	185,817
	Thereafter	1,410,600
		$	2,166,677

LOANS_RECEIVABLE_AND_OTHER_INV1

LOANS RECEIVABLE AND OTHER INVESTMENTS (Tables)	9 Months Ended
	Sep. 30, 2014
Loans Receivable and Other Investments [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
	As of September 30, 2014, the Company’s loans receivable and other investments consisted of the following (dollars in thousands):
	Investment	Quantity	Facility Type	Principal Balance as of September 30, 2014		Book Value as of September 30, 2014		Weighted Average Contractual Rate		Weighted Average Annualized Effective Rate		Maturity Date
	Loans Receivable:
	Mortgage	4	Skilled Nursing / Senior Housing / Acute Care Hospital	$	150,112	$	150,515	8.2	%	8.1	%	10/31/16 - 1/31/18
	Construction	3	Acute Care Hospital / Memory Care	62,541		62,845		7.5	%	7.3	%	9/30/16 - 10/31/18
	Mezzanine	2	Skilled Nursing / Senior Housing	21,730		21,797		11.3	%	11.1	%	12/27/14 - 08/31/17
	Pre-development	5	Senior Housing	3,572		3,696		9	%	8.2	%	8/16/15 - 09/09/17
		14		237,955		238,853		8.3	%	8.2	%
	Other Investments:
	Preferred Equity	4	Senior Housing	11,631		11,821		11.9	%	11.9	%	NA
	Total	18		$	249,586	$	250,674	8.5	%	8.4	%

DEBT_Tables

DEBT (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Mortgage Indebtness	'
	The Company’s mortgage notes payable consisted of the following (dollars in thousands):
	Interest Rate Type	Book Value as of			Book Value as of			Weighted Average			Maturity
		30-Sep-14			December 31, 2013			Effective Interest Rate at			Date
								30-Sep-14
	Fixed Rate	$	124,714		$	54,688		3.96	%		May 2031 - August 2051
	Variable Rate	—			86,640			NA			NA
		$	124,714		$	141,328		3.96	%
Schedule of Maturities of Debt	'
	The following is a schedule of maturities for the Company’s outstanding debt as of September 30, 2014 (in thousands):
			Mortgage			Senior Notes			Revolving Credit Facility (1) (2)			Total
			Indebtedness
	October 1, 2014 through December 31, 2014		$	691		$	—		$	—		$	691
	2015		2,823			—			—			2,823
	2016		2,917			—			—			2,917
	2017		3,013			—			—			3,013
	2018		3,114			—			614,000			617,114
	Thereafter		112,156			550,000			—			662,156
			$	124,714		$	550,000		$	614,000		$	1,288,714
	(1) Subject to a one-year extension option.
	(2) On October 10, 2014, the Operating Partnership converted $200.0 million of the outstanding borrowings under the Revolving Credit Facility to a term loan.

FAIR_VALUE_DISCLOSURES_Tables

FAIR VALUE DISCLOSURES (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair Value, by Balance Sheet Grouping	'
	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of September 30, 2014 and December 31, 2013 whose carrying amounts do not approximate their fair value (in thousands):
		September 30, 2014								December 31, 2013
		Face				Carrying		Fair		Face		Carrying		Fair
		Value (1)				Amount (2)		Value		Value (1)		Amount (2)		Value
	Financial assets:
	Loans receivable	$	237,955			$	238,853	$	237,385	$	176,558	$	177,509	$	176,985
	Preferred equity investments	11,631				11,821		12,268		7,695		7,784		7,950
	Financial liabilities:
	Senior Notes	550,000				550,000		547,000		411,250		414,402		421,122
	Mortgage indebtedness	124,714				124,714		108,467		141,328		141,328		130,622
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
	During the nine months ended September 30, 2014, the Company recorded the following amounts measured at fair value (in thousands):
						Fair Value Measurements Using
						Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
		Total				(Level 1)		(Level 2)		(Level 3)
	Recurring Basis:
	Contingent consideration liability	$	4,600			$	—	$	—	$	4,600
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
	Balance as of December 31, 2013		$	7,500
	New contingent liability		3,200
	Decrease in contingent liability		(860		)
	Payment of contingent liability		(5,240		)
	Balance as of September 30, 2014		$	4,600
Recurring [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair Value Measurements, Recurring and Nonrecurring	'
	The Company determined the fair value of financial instruments as of September 30, 2014 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):
						Fair Value Measurements Using
						Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
		Total				(Level 1)		(Level 2)		(Level 3)
	Financial assets:
	Loans receivable	$	237,385			$	—	$	—	$	237,385
	Preferred equity investments	12,268				—		—		12,268
	Financial liabilities:
	Senior Notes	547,000				—		547,000		—
	Mortgage indebtedness	108,467				—		—		108,467

EQUITY_Tables

EQUITY (Tables)	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Schedule of Dividends Paid	'
	The following table lists the cash dividends on common stock declared and paid by the Company during the nine months ended September 30, 2014:
	Declaration Date	Record Date	Amount Per Share		Dividend Payable Date
	23-Jan-14	15-Feb-14	$	0.36	28-Feb-14
	5-May-14	15-May-14	0.38		30-May-14
	30-Jul-14	15-Aug-14	0.38		29-Aug-14

EARNINGS_PER_COMMON_SHARE_Tabl

EARNINGS PER COMMON SHARE (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted	'
	The following table illustrates the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2014 and 2013 (in thousands, except share and per share amounts):
		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
	Numerator
	Net income attributable to common stockholders	$	14,643	$	9,242	$	17,020	$	15,310
	Denominator
	Basic weighted average common shares	47,359,949		37,358,334		43,358,620		37,334,120
	Dilutive stock options and restricted stock units	517,253		470,239		481,930		443,338
	Diluted weighted average common shares	47,877,202		37,828,573		43,840,550		37,777,458
	Net income attributable to common stockholders, per:
	Basic common share	$	0.31	$	0.25	$	0.39	$	0.41
	Diluted common share	$	0.31	$	0.24	$	0.39	$	0.41

SUMMARIZED_CONDENSED_CONSOLIDA1

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2014
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]	'
Schedule of Condensed Balance Sheet	'
	CONDENSED CONSOLIDATING BALANCE SHEET
	September 30, 2014
	(in thousands)
	(unaudited)
		Parent				Issuers				Combined				Combined Non-				Elimination				Consolidated
		Company								Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	63			$	—			$	1,426,998			$	141,207			$	—			$	1,568,268
	Loans receivable and other investments, net	—				—				250,674				—				—				250,674
	Cash and cash equivalents	21,475				—				—				4,004				—				25,479
	Restricted cash	—				—				160				6,377				—				6,537
	Deferred tax assets	24,212				—				—				—				—				24,212
	Prepaid expenses, deferred financing costs and other assets	977				20,920				112,615				7,684				—				142,196
	Intercompany	230,614				965,828				—				—				(1,196,442		)		—
	Investment in subsidiaries	417,157				602,179				24,887				—				(1,044,223		)		—
	Total assets	$	694,498			$	1,588,927			$	1,815,334			$	159,272			$	(2,240,665	)		$	2,017,366
	Liabilities
	Mortgage notes	$	—			$	—			$	—			$	124,714			$	—			$	124,714
	Revolving credit facility	—				614,000				—				—				—				614,000
	Senior unsecured notes	—				550,000				—				—				—				550,000
	Accounts payable and accrued liabilities	6,536				7,770				24,864				1,549				—				40,719
	Tax liability	24,212				—				—				—				—				24,212
	Intercompany	—				—				1,191,119				5,323				(1,196,442		)		—
	Total liabilities	30,748				1,171,770				1,215,983				131,586				(1,196,442		)		1,353,645
	Total equity	663,750				417,157				599,351				27,686				(1,044,223		)		663,721
	Total liabilities and equity	$	694,498			$	1,588,927			$	1,815,334			$	159,272			$	(2,240,665	)		$	2,017,366
	CONDENSED CONSOLIDATING BALANCE SHEET
	December 31, 2013
	(in thousands)
		Parent				Issuers				Combined				Combined  Non-				Elimination				Consolidated
		Company								Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	101			$	—			$	751,771			$	163,546			$	—			$	915,418
	Loans receivable and other investments, net	—				—				185,293				—				—				185,293
	Cash and cash equivalents	3,551				—				—				757				—				4,308
	Restricted cash	—				—				121				5,231				—				5,352
	Deferred tax assets	24,212				—				—				—				—				24,212
	Prepaid expenses, deferred financing costs and other assets	1,217				9,207				46,694				6,134				—				63,252
	Intercompany	63,125				270,194				—				42,637				(375,956		)		—
	Investment in subsidiaries	398,640				537,505				25,205				—				(961,350		)		—
	Total assets	$	490,846			$	816,906			$	1,009,084			$	218,305			$	(1,337,306	)		$	1,197,835
	Liabilities
	Mortgage notes	$	—			$	—			$	—			$	141,328			$	—			$	141,328
	Secured revolving credit facility	—				—				135,500				—				—				135,500
	Senior unsecured notes	—				414,402				—				—				—				414,402
	Accounts payable and accrued liabilities	6,470				3,864				11,008				887				—				22,229
	Tax liability	24,212				—				—				—				—				24,212
	Intercompany	—				—				375,956				—				(375,956		)		—
	Total liabilities	30,682				418,266				522,464				142,215				(375,956		)		737,671
	Total equity	460,164				398,640				486,620				76,090				(961,350		)		460,164
	Total liabilities and equity	$	490,846			$	816,906			$	1,009,084			$	218,305			$	(1,337,306	)		$	1,197,835
Schedule of Condensed Income Statement	'
	CONDENSED CONSOLIDATING STATEMENT OF INCOME
	For the Three Months Ended September 30, 2014
	(dollars in thousands, except per share amounts)
	(unaudited)
		Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
										Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Revenues:
	Rental income	$	—			$	—			$	33,290			$	4,875			$	—			$	38,165
	Interest and other income	2				—				5,141				676				—				5,819
	Total revenues	2				—				38,431				5,551				—				43,984
	Expenses:
	Depreciation and amortization	13				—				8,288				1,461				—				9,762
	Interest	—				8,435				749				1,356				—				10,540
	General and administrative	3,573				—				2,133				520				—				6,226
	Total expenses	3,586				8,435				11,170				3,337				—				26,528
	Other (expense) income:
	Loss on extinguishment of debt	—				—				(158		)		—				—				(158		)
	Other income (expense)	—				—				(100		)		—				—				(100		)
	Total other (expense) income	—				—				(258		)		—				—				(258		)
	Income in subsidiary	20,788				29,223				1,304				—				(51,315		)		—
	Net income	17,204				20,788				28,307				2,214				(51,315		)		17,198
	Net loss attributable to noncontrolling interests	—				—				—				6				—				6
	Net income attributable to Sabra Health Care REIT, Inc.	17,204				20,788				28,307				2,220				(51,315		)		17,204
	Preferred stock dividends	(2,561		)		—				—				—				—				(2,561		)
	Net income attributable to common stockholders	$	14,643			$	20,788			$	28,307			$	2,220			$	(51,315	)		$	14,643
	Net income attributable to common stockholders, per:
	Basic common share																					$	0.31
	Diluted common share																					$	0.31
	Weighted-average number of common shares outstanding, basic																					47,359,949
	Weighted-average number of common shares outstanding, diluted																					47,877,202
	CONDENSED CONSOLIDATING STATEMENT OF INCOME
	For the Three Months Ended September 30, 2013
	(dollars in thousands, except per share amounts)
	(unaudited)
		Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
										Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Revenues:
	Rental income	$	—			$	—			$	24,380			$	7,319			$	—			$	31,699
	Interest and other income	13				—				1,214				—				—				1,227
	Total revenues	13				—				25,594				7,319				—				32,926
	Expenses:
	Depreciation and amortization	13				—				6,365				1,880				—				8,258
	Interest	—				7,147				817				1,775				—				9,739
	General and administrative	2,996				—				41				20				—				3,057
	Total expenses	3,009				7,147				7,223				3,675				—				21,054
	Other (expense) income:
	Loss on extinguishment of debt	—				—				(351		)		—				—				(351		)
	Other income (expense)	—				—				300				—				—				300
	Total other (expense) income	—				—				(51		)		—				—				(51		)
	Income in subsidiary	14,817				21,964				982				—				(37,763		)		—
	Net income	11,821				14,817				19,302				3,644				(37,763		)		11,821
	Preferred dividends	(2,579		)		—				—				—				—				(2,579		)
	Net income attributable to common stockholders	$	9,242			$	14,817			$	19,302			$	3,644			$	(37,763	)		$	9,242
	Net loss attributable to common stockholders, per:
	Basic common share																					$	0.25
	Diluted common share																					$	0.24
	Weighted-average number of common shares outstanding, basic																					37,358,334
	Weighted-average number of common shares outstanding, diluted																					37,828,573
	CONDENSED CONSOLIDATING STATEMENT OF INCOME
	For the Nine Months Ended September 30, 2014
	(dollars in thousands, except per share amounts)
(unaudited)
	Parent Company					Issuers				Combined					Combined Non-				Elimination				Consolidated
										Guarantor					Guarantor
										Subsidiaries					Subsidiaries
Revenues:
Rental income	$	—				$	—			$	97,384				$	14,359			$	—			$	111,743
Interest and other income	9					—				14,039					2,016				—				16,064
Total revenues	9					—				111,423					16,375				—				127,807
Expenses:
Depreciation and amortization	38					—				24,642					4,187				—				28,867
Interest	—					24,189				4,642					3,837				—				32,668
General and administrative	12,133					2				6,142					1,728				—				20,005
Total expenses	12,171					24,191				35,426					9,752				—				81,540
Other (expense) income:
Loss on extinguishment of debt	—					(21,846		)		(472		)			(136		)		—				(22,454		)
Other income (expense)	—					—				860					—				—				860
Total other (expense) income	—					(21,846		)		388					(136		)		—				(21,594		)
Income in subsidiary	36,864					82,901				4,368					—				(124,133		)		—
Net income	24,702					36,864				80,753					6,487				(124,133		)		24,673
Net loss attributable to noncontrolling interests	—					—				—					29				—				29
Net income attributable to Sabra Health Care REIT, Inc.	24,702					36,864				80,753					6,516				(124,133		)		24,702
Preferred dividends	(7,682		)			—				—					—				—				(7,682		)
Net income attributable to common stockholders	$	17,020		—		$	36,864			$	80,753		—		$	6,516			$	(124,133	)		$	17,020
Net income attributable to common stockholders, per:
Basic common share																							$	0.39
Diluted common share																							$	0.39
Weighted-average number of common shares outstanding, basic																							43,358,620
Weighted-average number of common shares outstanding, diluted																							43,840,550
CONDENSED CONSOLIDATING STATEMENT OF INCOME
For the Nine Months Ended September 30, 2013
(dollars in thousands, except per share amounts)
(unaudited)
	Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Revenues:
Rental income	$	—			$	—			$	72,733			$	21,959			$	—			$	94,692
Interest and other income	82				—				2,449				—				—				2,531
Total revenues	82				—				75,182				21,959				—				97,223
Expenses:
Depreciation and amortization	38				—				18,983				5,705				—				24,726
Interest	—				21,585				2,797				5,502				—				29,884
General and administrative	10,671				4				453				68				—				11,196
Total expenses	10,709				21,589				22,233				11,275				—				65,806
Other (expense) income:
Loss on extinguishment of debt	—				(9,750		)		(351		)		—				—				(10,101		)
Other income (expense)	—				—				(600		)		—				—				(600		)
Total other (expense) income	—				(9,750		)		(951		)		—				—				(10,701		)
Income in subsidiary	31,343				62,682				2,892				—				(96,917		)		—
Net income	20,716				31,343				54,890				10,684				(96,917		)		20,716
Preferred dividends	(5,406		)		—				—				—				—				(5,406		)
Net income attributable to common stockholders	$	15,310			$	31,343			$	54,890			$	10,684			$	(96,917	)		$	15,310
Net income attributable to common stockholders, per:
Basic common share																					$	0.41
Diluted common share																					$	0.41
Weighted-average number of common shares outstanding, basic																					37,334,120
Weighted-average number of common shares outstanding, diluted																					37,777,458
Schedule of Condensed Cash Flow Statement	'
	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
	For the Nine Months Ended September 30, 2014
	(in thousands)
	(unaudited)
		Parent Company				Issuers				Combined				Combined  Non-					Elimination				Consolidated
										Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Net cash (used in) provided by operating activities	$	40,289			$	—			$	—			$	30,950				$	—			$	71,239
	Cash flows from investing activities:
	Acquisitions of real estate	—				—				(713,778		)		(8,101		)			—				(721,879		)
	Origination of loans receivable	—				—				(59,256		)		—					—				(59,256		)
	Preferred equity investment	—				—				(11,300		)		—					—				(11,300		)
	Additions to real estate	—				—				(1,128		)		(23		)			—				(1,151		)
	Repayment of loans receivable	—				—				287				—					—				287
	Investment in subsidiaries	(12,288		)		(12,288		)		—				—					24,576				—
	Intercompany financing	(182,248		)		(915,786		)		—				—					1,098,034				—
	Net cash used in investing activities	(194,536		)		(928,074		)		(785,175		)		(8,124		)			1,122,610				(793,299		)
	Cash flows from financing activities:
	Proceeds from issuance of senior unsecured notes	—				350,000				—				—			—		—				350,000
	Principal payments on senior unsecured notes	—				(211,250		)		—				—					—				(211,250		)
	Proceeds from revolving credit facility	—				604,000				95,000				—					—				699,000
	Payments on revolving credit facility	—				—				(220,500		)		—					—				(220,500		)
	Proceeds from mortgage notes	—				—				—				57,703					—				57,703
	Principal payments on mortgage notes	—				—				—				(88,419		)			—				(88,419		)
	Payments of deferred financing costs	—				(9,212		)		(5,111		)		(1,151		)			—				(15,474		)
	Issuance of common stock	229,825				—				—				—					—				229,825
	Dividends paid on common and preferred stock	(57,654		)		—				—				—					—				(57,654		)
	Contribution from Parent	—				12,288				—				12,288					(24,576		)		—
	Intercompany financing	—				182,248				915,786				—					(1,098,034		)		—
	Net cash provided by (used in) financing activities	172,171				928,074				785,175				(19,579		)			(1,122,610		)		743,231
	Net increase in cash and cash equivalents	17,924				—				—				3,247					—				21,171
	Cash and cash equivalents, beginning of period	3,551				—				—				757					—				4,308
	Cash and cash equivalents, end of period	$	21,475			$	—			$	—			$	4,004				$	—			$	25,479
	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
	For the Nine Months Ended September 30, 2013
	(in thousands)
	(unaudited)
		Parent Company				Issuers				Combined				Combined  Non-				Elimination				Consolidated
										Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Net cash provided by operating activities	$	36,878			$	—			$	—			$	12,333			$	—			$	49,211
	Cash flows from investing activities:
	Acquisitions of real estate	—				—				(6,175		)		—				—				(6,175		)
	Origination of note receivable	—				—				(26,393		)		—				—				(26,393		)
	Preferred equity investment	—				—				(6,624		)		—				—				(6,624		)
	Additions to real estate	—				—				(388		)		—				—				(388		)
	Net proceeds from the sale of real estate	—				—				—				2,208				—				2,208
	Distribution from subsidiaries	3,345				3,345				—				—				(6,690		)		—
	Intercompany financing	(52,041		)		(132,883		)		—				—				184,924				—
	Net cash (used in) provided by investing activities	(48,696		)		(129,538		)		(39,580		)		2,208				178,234				(37,372		)
	Cash flows from financing activities:
	Proceeds from issuance of senior unsecured notes	—				200,000				—				—				—				200,000
	Principal payments on senior unsecured notes	—				(113,750		)		—				—				—				(113,750		)
	Payments on secured revolving credit facility	—				—				(92,500		)		—				—				(92,500		)
	Principal payments on mortgage notes	—				—				—				(10,081		)		—				(10,081		)
	Payments of deferred financing costs	—				(5,408		)		(3,011		)		(179		)		—				(8,598		)
	Issuance of common stock	(2,950		)		—				—				—				—				(2,950		)
	Issuance of preferred stock	138,257				—				—				—				—				138,257
	Dividends paid	(42,677		)		—				—				—				—				(42,677		)
	Distribution to Parent	—				(3,345		)		—				(3,345		)		6,690				—
	Intercompany financing	—				52,041				135,091				(2,208		)		(184,924		)		—
	Net cash provided by (used in) financing activities	92,630				129,538				39,580				(15,813		)		(178,234		)		67,701
	Net increase (decrease) in cash and cash equivalents	80,812				—				—				(1,272		)		—				79,540
Cash and cash equivalents, beginning of period	15,075				—				—				2,026				—				17,101
Cash and cash equivalents, end of period	$	95,887			$	—			$	—			$	754			$	—			$	96,641

PRO_FORMA_FINANCIAL_INFORMATIO1

PRO FORMA FINANCIAL INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2014
PRO FORMA FINANCIAL INFORMATION [Abstract]	'
Business Acquisition, Pro Forma Information [Table Text Block]	'
	This pro forma information does not purport to represent what the actual results of operations of the Company would have been had these acquisitions occurred on January 1, 2013, nor does it purport to predict the results of operations for future periods.
		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
		(in thousands, except share and per share amounts)
	Revenues	$	53,706	$	46,572	$	160,491	$	138,159
	Depreciation and amortization	13,483		13,004		40,573		38,933
	Net income attributable to common stockholders	22,456		16,328		40,221		39,818
	Net income attributable to common stockholders, per:
	Basic common share	$	0.47	$	0.44	$	0.93	$	1.07
	Diluted common share	$	0.47	$	0.43	$	0.92	$	1.05
	Weighted-average number of common shares outstanding, basic	47,359,949		37,358,334		43,358,620		37,334,120
	Weighted-average number of common shares outstanding, diluted	47,877,202		37,828,573		43,840,550		37,777,458

RECENT_REAL_ESTATE_ACQUISITION2

RECENT REAL ESTATE ACQUISITIONS (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 25, 2014

Feb. 14, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Feb. 14, 2014

Sep. 30, 2014

Sep. 25, 2014

Feb. 14, 2014

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Holiday Portfolio [Member]

Nye Portfolio [Member]

Nye Portfolio [Member]

Nye Portfolio [Member]

Tenant Origination and Absorption Costs [Member]

Tenant Relationship [Member]

Skilled Nursing/Transitional Care Facilities [Member]

Skilled Nursing/Transitional Care Facilities [Member]

Senior Housing Facilities [Member]

Senior Housing Facilities [Member]

Senior Housing Facilities [Member]

Renewal_Options

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Nye Portfolio [Member]

Series of Individually Immaterial Business Acquisitions [Member]

Holiday Portfolio [Member]

Nye Portfolio [Member]

States

Facilities

unit

Facilities

unit

unit

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Change in fair value of contingent consideration

'

'

$860,000

'

'

'

'

'

$100,000

$200,000

'

'

'

'

'

'

'

Number of acquired properties

'

'

'

'

'

'

'

'

'

'

'

'

6

4

27

21

2

Number of states where entity operates

'

'

'

'

'

'

15

'

'

'

'

'

'

'

'

'

'

Purchase price

'

'

'

'

'

690,800,000

'

'

'

'

'

'

'

'

'

'

'

Recognized Identifiable Assets Acquired

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Land

'

'

'

'

54,387,000

54,387,000

'

'

'

'

'

'

'

'

'

'

'

Building and Improvements

'

'

'

'

625,536,000

625,536,000

'

'

'

'

'

'

'

'

'

'

'

Intangibles

'

'

'

'

'

'

'

'

'

'

7,924,000

2,991,000

'

'

'

'

'

Total Consideration

'

'

'

'

690,838,000

690,838,000

'

'

'

'

'

'

'

'

'

'

'

Acquired finite-lived intangible assets, weighted average useful life

'

'

'

'

'

'

'

'

'

'

'14 years

'24 years

'

'

'

'

'

Revenues

43,984,000

32,926,000

127,807,000

97,223,000

3,900,000

8,300,000

'

'

'

'

'

'

'

'

'

'

'

Net Income Attributable to Parent

17,204,000

11,821,000

24,702,000

20,716,000

1,000,000

3,300,000

'

'

'

'

'

'

'

'

'

'

'

Payments to Acquire Businesses, Gross

'

'

'

'

'

'

550,000,000

90,000,000

'

'

'

'

'

'

'

'

'

Lessor Leasing Arrangements, Operating Leases, Term of Contract

'

'

'

'

'

'

'15 years

'

'

'

'

'

'

'

'

'

'

Lessor Leasing Arrangements, Operating Leases, Number of Lease Renewal Options

'

'

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

Lessor Leasing Arrangements, Operating Leases, Renewal Term

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

Lessor Leasing Arrangements, Operating Leases, Annual Rent Expense

'

'

'

'

'

'

30,300,000

'

'

'

'

'

'

'

'

'

'

Lessor Leasing Arrangements, Operating Leases, Annual Rent Escalator

'

'

'

'

'

'

4.00%

'

'

'

'

'

'

'

'

'

'

Minimum annual rent escalator for remainder of the lease term

'

'

'

'

'

'

3.50%

'

'

'

'

'

'

'

'

'

'

Operating Leases, Expected Annual Lease Revenue

'

'

'

'

'

'

39,300,000

'

'

'

'

'

'

'

'

'

'

Contingent consideration liability

'

'

'

'

'

'

'

$3,200,000

$3,400,000

$3,400,000

'

'

'

'

'

'

'

REAL_ESTATE_INVESTMENTS_Detail

REAL ESTATE INVESTMENTS (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Real Estate Properties [Line Items]	'	'
Buildings and improvements	$1,476,202	$879,926
Furniture and equipment	80,977	50,567
Land improvements	4,392	4,392
Land	185,998	131,611
Total Real Estate at Cost	1,747,569	1,066,496
Accumulated Depreciation	-179,301	-151,078
Total Real Estate Investments, Net	1,568,268	915,418
Operating Segments [Member]	'	'
Real Estate Properties [Line Items]	'	'
Number of Properties	154	121
Number of Beds/Units	16,402	12,468
Total Real Estate at Cost	1,747,315	1,066,242
Accumulated Depreciation	-179,110	-150,925
Total Real Estate Investments, Net	1,568,205	915,317
Skilled Nursing/Transitional Care Facilities [Member]	'	'
Real Estate Properties [Line Items]	'	'
Number of Properties	102	96
Number of Beds/Units	11,460	10,826
Total Real Estate at Cost	825,378	737,188
Accumulated Depreciation	-151,842	-132,068
Total Real Estate Investments, Net	673,536	605,120
Senior Housing [Member]	'	'
Real Estate Properties [Line Items]	'	'
Number of Properties	50	23
Number of Beds/Units	4,818	1,518
Total Real Estate at Cost	746,130	153,247
Accumulated Depreciation	-17,395	-13,337
Total Real Estate Investments, Net	728,735	139,910
Acute Care Hospital [Member]	'	'
Real Estate Properties [Line Items]	'	'
Number of Properties	2	2
Number of Beds/Units	124	124
Total Real Estate at Cost	175,807	175,807
Accumulated Depreciation	-9,873	-5,520
Total Real Estate Investments, Net	165,934	170,287
Corporate [Member]	'	'
Real Estate Properties [Line Items]	'	'
Total Real Estate at Cost	254	254
Accumulated Depreciation	-191	-153
Total Real Estate Investments, Net	$63	$101

REAL_ESTATE_INVESTMENTS_Operat

REAL ESTATE INVESTMENTS Operating Lease (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Property Subject to or Available for Operating Lease [Line Items]	'	'
Security Deposit Liability	$15,600,000	$1,600,000
Operating Leases, Weighted Average Lease Expiration Period	'11 years	'
Operating Leases, Future Minimum Payments Receivable [Abstract]	'	'
October 1, 2014 through December 31, 2014	41,907,000	'
2015	171,645,000	'
2016	175,883,000	'
2017	180,825,000	'
2018	185,817,000	'
Thereafter	1,410,600,000	'
Total	$2,166,677,000	'
Minimum [Member]	'	'
Property Subject to or Available for Operating Lease [Line Items]	'	'
Operating Leases, Lease Expiration Period	'6 years	'
Maximum [Member]	'	'
Property Subject to or Available for Operating Lease [Line Items]	'	'
Operating Leases, Lease Expiration Period	'18 years	'
Operating Segments [Member]	'	'
Property Subject to or Available for Operating Lease [Line Items]	'	'
Number of Real Estate Properties	154	121
Operating Segments [Member] | Genesis Healthcare, Inc [Member]	'	'
Property Subject to or Available for Operating Lease [Line Items]	'	'
Number of Real Estate Properties	81	'

LOANS_RECEIVABLE_AND_OTHER_INV2

LOANS RECEIVABLE AND OTHER INVESTMENTS (Details) (USD $)

9 Months Ended

0 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Aug. 15, 2014

Aug. 15, 2014

Sep. 30, 2014

Sep. 30, 2014

Mar. 05, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Aug. 15, 2014

Investment

Meridian Mezzanine Loan [Member]

Meridian Mezzanine Loan [Member]

Mortgage Loans Receivable [Member]

Construction Mortgage Loans [Member]

Mezzanine Investments [Member]

Mezzanine Investments [Member]

Chai Mezzanine Loan Portfolio [Member]

Pre-Development Loans [Member]

Affiliated Entity [Member]

Facilities

Facilities

Facilities

Facilities

loan

Wholly Owned Subsidiary [Member]

loan

unit

Accounts, Notes, Loans and Financing Receivable [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Number of Facilities, Option to Purchase Exercised

'

'

'

'

'

'

'

2

'

'

'

'

Acquisition of Real Estate Held-for-investment

'

'

'

'

'

'

'

$24,500,000

'

'

'

'

Proceeds from Collection of Loans Receivable

'

'

'

'

'

'

'

5,800,000

'

'

'

'

Payments to Acquire Real Estate Held-for-investment

'

'

'

'

'

'

'

18,700,000

'

'

'

'

Loans and Leases Receivable, Number of Loans

14

'

'

'

'

4

3

'

2

'

5

'

Loans and Leases Receivable, Gross

237,955,000

'

'

'

15,500,000

150,112,000

62,541,000

'

21,730,000

6,500,000

3,572,000

'

Repayment of preferred equity investments

6,949,000

0

'

'

'

'

'

'

'

'

'

8,300,000

Loans and Leases Receivable, Net Amount

'

'

'

'

7,200,000

'

'

'

'

'

'

'

Loans and Leases Receivable, Lease Term

'

'

'

'3 years

'

'

'

'

'

'

'

'

Loans receivable and other investments, net

238,853,000

'

'

'

'

150,515,000

62,845,000

'

21,797,000

'

3,696,000

'

Loans and Leases Receivable, Fixed Interest Rate

8.30%

'

'

'

11.00%

8.20%

7.50%

'

11.30%

'

9.00%

'

Loans And Leases Receiavble, Effective Interest Rate

8.16%

'

'

'

'

8.10%

7.30%

'

11.10%

'

8.20%

'

Loans and Leases Receivable, Number of Units in Real Estate Property Used as Collateral

'

'

'

'

'

'

'

'

'

10

'

'

Loans and Leases Receivable, Option to Purchase

'

'

'

'

'

'

'

'

'

25,500,000

'

'

Preferred Equity Investments, Number

4

'

'

'

'

'

'

'

'

'

'

'

Preferred equity investment, Face Value

11,631,000

'

7,695,000

'

'

'

'

'

'

'

'

'

Preferred Equity Investment, Carrying Amount

11,821,000

'

'

'

'

'

'

'

'

'

'

'

Preferred Equity Investment, Weighted Average Contractual Rate

11.90%

'

'

'

'

'

'

'

'

'

'

'

Preferred Equity Investment, Weighted Average Effective Rate

11.90%

'

'

'

'

'

'

'

'

'

'

'

Number of Investments

18

'

'

'

'

'

'

'

'

'

'

'

Investment Owned, Balance, Principal Amount

249,586,000

'

'

'

'

'

'

'

'

'

'

'

Investments

$250,674,000

'

'

'

'

'

'

'

'

'

'

'

Investments, Weighted Average Contractual Rate

8.50%

'

'

'

'

'

'

'

'

'

'

'

Investments, Weighted Average Effective Rate

8.40%

'

'

'

'

'

'

'

'

'

'

'

DEBT_Details

DEBT (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

9 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

0 Months Ended

0 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Jan. 23, 2014

23-May-13

23-May-13

23-May-13

Feb. 11, 2014

Jan. 08, 2014

Jun. 24, 2013

Sep. 30, 2014

Dec. 31, 2013

Oct. 27, 2010

Jun. 24, 2013

Sep. 30, 2014

Sep. 10, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Jul. 26, 2012

1-May-14

Sep. 30, 2014

Apr. 08, 2014

Jan. 21, 2014

Dec. 31, 2013

Sep. 30, 2014

Jan. 23, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Oct. 10, 2014

Oct. 10, 2014

Oct. 10, 2014

Oct. 10, 2014

Oct. 10, 2014

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Senior Unsecured Notes due 2021 [Member]

Senior Unsecured Notes Due 2023 [Member]

Senior Unsecured Notes Due 2023 [Member]

Senior Unsecured Notes Due 2023 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

Additional Senior Notes [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Debt Instrument, Redemption, Period One [Member]

Investment Grade Credit Rating [Member]

Investment Grade Credit Rating [Member]

Investment Grade Credit Rating [Member]

Investment Grade Credit Rating [Member]

Investment Grade Credit Rating [Member]

Investment Grade Credit Rating [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

London Interbank Offered Rate (LIBOR) [Member]

Prior to June 2018 [Member]

Prior to June 2016 [Member]

Prior to November 2013 [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Fixed Rate Mortgages [Member]

Senior Unsecured Notes due 2021 [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

Additional Senior Unsecured Notes due 2021 [Member]

Additional Senior Unsecured Notes due 2021 [Member]

2014 Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

Subsequent Event [Member]

Minimum [Member]

Maximum [Member]

Federal Funds Rate [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Base Rate [Member]

Base Rate [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

2014 Revolving Credit Facility [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Base Rate [Member]

Base Rate [Member]

Revolving Credit Facility [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Principal Outstaning, Fixed Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$124,714,000

'

'

$54,688,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Principal Outstaning, Variable Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

86,640,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Total Principal Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

124,714,000

'

'

141,328,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Description of Variable Rate Basis

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'federal funds rate

'one-month LIBOR

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Basis Spread on Variable Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

1.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.00%

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

5.50%

5.38%

'

'

'

'

'

'

'

8.13%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.10%

4.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debtor Reorganization Items, Write-off of Deferred Financing Costs and Debt Discounts

'

'

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of Long-term Debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

29,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

350,000,000

200,000,000

'

'

'

'

'

'

'

225,000,000

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

11,600,000

44,800,000

'

'

'

'

'

'

'

'

'

'

150,000,000

'

'

'

Debt Instrument, Issued Price, Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

99.50%

'

'

'

Debt Instrument, Redemption Price, Principal Amount Redeemed

'

'

'

'

'

'

'

'

'

'

'

'

'

113,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed

'

'

'

'

'

'

'

'

'

'

35.00%

'

'

35.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

35.00%

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Redemption Price, Percentage, Using Proceeds of Specific Kinds of Equity Offerings

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

105.50%

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Debt

'

'

'

'

'

'

'

350,000,000

200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Debt, Net of Issuance Costs

'

'

'

'

'

'

'

340,800,000

194,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

145,800,000

'

'

'

'

Debt Instrument, Yield-to-Maturity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.59%

'

'

'

Debt Instrument, Redeemable, Redemption Price of Principal Amount, Percentage

'

'

'

'

'

'

'

'

'

'

105.38%

'

'

'

'

'

'

108.13%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

750,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Revolving Credit Conversion to Term Loan, Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

200,000,000

'

Debt Instrument, Term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

Line of Credit Facility, Accordion Feature, Additional Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Optional Extension Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Secured revolving credit facility

614,000,000

'

614,000,000

'

135,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

614,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Refianced, Write-off of Unamortized Financing Costs

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Current Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

650,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Interest Rate During Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.00%

2.60%

1.00%

1.60%

'

'

'

'

'

'

'

'

'

'

0.90%

1.70%

0.00%

0.70%

'

'

'

'

'

Line of Credit Facility, Commitment Fee Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.13%

0.30%

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Interest Rate at Period End

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.46%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.25%

0.35%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Expense

10,540,000

9,739,000

32,668,000

29,884,000

'

300,000

2,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Commitment Fee Amount

'

'

'

'

'

500,000

1,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of deferred financing costs

900,000

800,000

2,812,000

2,395,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Payable

7,900,000

'

7,900,000

'

4,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain (Loss) on extinguishment of debt

-158,000

-351,000

-22,454,000

-10,101,000

'

'

'

'

'

'

'

'

'

'

21,600,000

-9,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gains (Losses) on Extinguishment of Debt, before Write off of Deferred Debt Issuance Cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-20,800,000

9,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Write off of Deferred Debt Issuance Cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

800,000

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt, Weighted Average Interest Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

3.96%

'

'

'

3.96%

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt

1,288,714,000

'

1,288,714,000

'

'

'

'

'

'

'

'

'

211,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

124,714,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Extinguishment of Debt, Amount

'

'

'

'

'

'

'

'

'

'

'

$400,000

$210,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Redemption Price, Percentage

'

'

'

'

'

'

'

'

'

100.00%

'

109.49%

109.84%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

'

'

'

'

'

'

'

'

'

'

'

DEBT_Schedule_of_Debt_Maturiti

DEBT Schedule of Debt Maturities (Details) (USD $)	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Jan. 08, 2014
In Thousands, unless otherwise specified		Mortgage Indebtedness [Member]	Senior Notes [Member]	Line of Credit [Member]	Senior Notes due 2018 [Member]
Debt Instrument [Line Items]	'	'	'	'	'
October 1, 2014 through December 31, 2014	$691	$691	$0	$0	'
2015	2,823	2,823	0	0	'
2016	2,917	2,917	0	0	'
2017	3,013	3,013	0	0	'
2018	617,114	3,114	0	614,000	'
Thereafter	662,156	112,156	550,000	0	'
Total	$1,288,714	$124,714	$550,000	$614,000	$211,300

FAIR_VALUE_DISCLOSURES_Details

FAIR VALUE DISCLOSURES (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Contingent consideration liability	'		$7,500
New contingent liability	3,200		'
Change in fair value of contingent consideration	-860		'
Payment of contingent consideration	-5,240		'
Loans receivable, Face Value	237,955	[1]	176,558	[1]
Preferred equity investment, Face Value	11,631		7,695
Preferred equity investments	12,268		'
Carrying Amount [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Loans receivable	238,853	[2]	177,509	[2]
Preferred equity investments	11,821		7,784
Fair Value [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Loans receivable	237,385		176,985
Preferred equity investments	12,268		7,950
Senior Notes [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Financial liabilities, Face Value	550,000	[1]	411,250	[1]
Senior Notes [Member] | Carrying Amount [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Financial liabilities	550,000	[2]	414,402	[2]
Senior Notes [Member] | Fair Value [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Financial liabilities	547,000		421,122
Mortgage indebtedness [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Financial liabilities, Face Value	124,714	[1]	141,328	[1]
Mortgage indebtedness [Member] | Carrying Amount [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Financial liabilities	124,714	[2]	141,328	[2]
Mortgage indebtedness [Member] | Fair Value [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'
Financial liabilities	$108,467		$130,622
[1]	(1) Face value represents amounts contractually due under the terms of the respective agreements.
[2]	(2) Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).

FAIR_VALUE_DISCLOSURES_Assets_

FAIR VALUE DISCLOSURES (Assets and Liabilities Measured on a Recurring and Nonrecurring Basis) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Preferred equity investments	$12,268	'
Contingent consideration liability	'	7,500
Recurring [Member] | Total [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Loans receivable	237,385	'
Preferred equity investments	12,268	'
Contingent consideration liability	4,600	'
Recurring [Member] | Total [Member] | Senior Notes [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	547,000	'
Recurring [Member] | Total [Member] | Mortgage indebtedness [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	108,467	'
Recurring [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Loans receivable	0	'
Preferred equity investments	0	'
Contingent consideration liability	0	'
Recurring [Member] | Level 1 [Member] | Senior Notes [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	0	'
Recurring [Member] | Level 1 [Member] | Mortgage indebtedness [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	0	'
Recurring [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Loans receivable	0	'
Preferred equity investments	0	'
Contingent consideration liability	0	'
Recurring [Member] | Level 2 [Member] | Senior Notes [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	547,000	'
Recurring [Member] | Level 2 [Member] | Mortgage indebtedness [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	0	'
Recurring [Member] | Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Loans receivable	237,385	'
Contingent consideration liability	4,600	'
Recurring [Member] | Level 3 [Member] | Senior Notes [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	0	'
Recurring [Member] | Level 3 [Member] | Mortgage indebtedness [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	$108,467	'

EQUITY_Details

EQUITY (Details) (USD $)

0 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

Jul. 30, 2014

12-May-14

5-May-14

Jan. 23, 2014

Mar. 21, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Oct. 03, 2014

Restricted Stock Units (RSUs) [Member]

Stock Options [Member]

At-the-Market Offering, Sales Agents [Member]

At-the-Market Offering, Sales Agents [Member]

Subsequent Event [Member]

Equity [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issuance, Shares

'

8,100,000

'

'

'

'

'

'

'

'

'

'

'

6,900,000

Stock issuance, Shares, Underwriters option

'

1,100,000

'

'

'

'

'

'

'

'

'

'

'

900,000

Preferred stock, shares issued

'

'

'

'

5,800,000

5,750,000

5,750,000

'

5,750,000

'

'

'

'

'

Common dividends, declared

$0.38

'

$0.38

$0.36

'

'

$1.12

$1.02

'

'

'

'

'

'

Stock-based compensation, issued during period (in shares)

'

'

'

'

'

'

'

'

'

200,000

11,515

'

'

'

Shares Paid for Tax Withholding for Share Based Compensation

'

'

'

'

'

'

5,100,000

'

'

'

'

'

'

'

Preferred Stock, Dividend Rate, Percentage

'

'

'

'

'

'

7.13%

'

'

'

'

'

'

'

Preferred Stock, Redemption Price Per Share

'

'

'

'

$25

'

'

'

'

'

'

'

'

'

Issuance of preferred stock

'

'

'

'

$138,300,000

'

$0

$138,257,000

'

'

'

'

'

'

Convertible Preferred Stock, Terms of Conversion

'

'

'

'

'

'

'1.7864

'

'

'

'

'

'

'

Common Stock, At The Market Stock Offering, Max Possible Gross Proceeds

'

'

'

'

'

'

100,000,000

'

'

'

'

'

'

'

Common Stock, At the Market Stock Offering, Sales Commision

'

'

'

'

'

'

2.00%

'

'

'

'

'

'

'

Common Stock, At the Market Stock Offering, Number of Shares Sold

'

'

'

'

'

400,000

600,000

'

'

'

'

'

'

'

Sale of Stock, Price Per Share

'

$28.35

'

'

'

'

'

'

'

'

'

'

'

$24.25

Share Price

'

'

'

'

'

'

'

'

'

'

'

$28.28

$28.05

'

Proceeds from Issuance of Common Stock

'

219,100,000

'

'

'

'

229,825,000

-2,950,000

'

'

'

10,300,000

16,900,000

160,600,000

Payments of Stock Issuance Costs

'

'

'

'

'

'

'

'

'

'

'

200,000

300,000

'

Common Stock, Amount Available for Future Issuance

'

'

'

'

'

'

'

'

'

'

'

'

$44,800,000

'

EARNINGS_PER_COMMON_SHARE_Deta

EARNINGS PER COMMON SHARE (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Numerator	'	'	'	'
Net Income Available to Common Stockholders, Basic	$14,643	$9,242	$17,020	$15,310
Denominator	'	'	'	'
Weighted-average number of common shares outstanding, basic	47,359,949	37,358,334	43,358,620	37,334,120
Dilutive stock options and restricted stock units (in shares)	517,253	470,239	481,930	443,338
Weighted-average number of common shares outstanding, diluted (in shares)	47,877,202	37,828,573	43,840,550	37,777,458
Basic common share	$0.31	$0.25	$0.39	$0.41
Diluted common share	$0.31	$0.24	$0.39	$0.41

EARNINGS_PER_COMMON_SHARE_Anti

EARNINGS PER COMMON SHARE Anti-dulitve Securities excluded from Calculation (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Restricted Stock Units (RSUs) [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	0	5,000	3,000
Stock Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	0	0	0

SUMMARIZED_CONDENSED_CONSOLIDA2

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Condensed Consolidating Balance Sheet) (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Assets	'	'	'	'
Real estate investments, net of accumulated depreciation	$1,568,268	$915,418	'	'
Loans receivable and other investments, net	250,674	185,293	'	'
Cash and cash equivalents	25,479	4,308	96,641	17,101
Restricted cash	6,537	5,352	'	'
Deferred tax assets	24,212	24,212	'	'
Prepaid expenses, deferred financing costs and other assets	142,196	63,252	'	'
Intercompany	0	0	'	'
Investment in subsidiaries	0	0	'	'
Total assets	2,017,366	1,197,835	'	'
Liabilities	'	'	'	'
Mortgage notes	124,714	141,328	'	'
Secured revolving credit facility	614,000	135,500	'	'
Senior unsecured notes	550,000	414,402	'	'
Accounts payable and accrued liabilities	40,719	22,229	'	'
Tax liability	24,212	24,212	'	'
Intercompany	0	0	'	'
Total liabilities	1,353,645	737,671	'	'
Equity	'	'	'	'
Total equity	663,721	460,164	423,190	305,488
Total liabilities and equity	2,017,366	1,197,835	'	'
Parent Company [Member]	'	'	'	'
Assets	'	'	'	'
Real estate investments, net of accumulated depreciation	63	101	'	'
Loans receivable and other investments, net	0	0	'	'
Cash and cash equivalents	21,475	3,551	95,887	15,075
Restricted cash	0	0	'	'
Deferred tax assets	24,212	24,212	'	'
Prepaid expenses, deferred financing costs and other assets	977	1,217	'	'
Intercompany	230,614	63,125	'	'
Investment in subsidiaries	417,157	398,640	'	'
Total assets	694,498	490,846	'	'
Liabilities	'	'	'	'
Mortgage notes	0	0	'	'
Secured revolving credit facility	0	0	'	'
Senior unsecured notes	0	0	'	'
Accounts payable and accrued liabilities	6,536	6,470	'	'
Tax liability	24,212	24,212	'	'
Intercompany	0	0	'	'
Total liabilities	30,748	30,682	'	'
Equity	'	'	'	'
Total equity	663,750	460,164	'	'
Total liabilities and equity	694,498	490,846	'	'
Issuers [Member]	'	'	'	'
Assets	'	'	'	'
Real estate investments, net of accumulated depreciation	0	0	'	'
Loans receivable and other investments, net	0	0	'	'
Cash and cash equivalents	0	0	0	0
Restricted cash	0	0	'	'
Deferred tax assets	0	0	'	'
Prepaid expenses, deferred financing costs and other assets	20,920	9,207	'	'
Intercompany	965,828	270,194	'	'
Investment in subsidiaries	602,179	537,505	'	'
Total assets	1,588,927	816,906	'	'
Liabilities	'	'	'	'
Mortgage notes	0	0	'	'
Secured revolving credit facility	614,000	0	'	'
Senior unsecured notes	550,000	414,402	'	'
Accounts payable and accrued liabilities	7,770	3,864	'	'
Tax liability	0	0	'	'
Intercompany	0	0	'	'
Total liabilities	1,171,770	418,266	'	'
Equity	'	'	'	'
Total equity	417,157	398,640	'	'
Total liabilities and equity	1,588,927	816,906	'	'
Combined Guarantor Subsidiaries [Member]	'	'	'	'
Assets	'	'	'	'
Real estate investments, net of accumulated depreciation	1,426,998	751,771	'	'
Loans receivable and other investments, net	250,674	185,293	'	'
Cash and cash equivalents	0	0	0	0
Restricted cash	160	121	'	'
Deferred tax assets	0	0	'	'
Prepaid expenses, deferred financing costs and other assets	112,615	46,694	'	'
Intercompany	0	0	'	'
Investment in subsidiaries	24,887	25,205	'	'
Total assets	1,815,334	1,009,084	'	'
Liabilities	'	'	'	'
Mortgage notes	0	0	'	'
Secured revolving credit facility	0	135,500	'	'
Senior unsecured notes	0	0	'	'
Accounts payable and accrued liabilities	24,864	11,008	'	'
Tax liability	0	0	'	'
Intercompany	1,191,119	375,956	'	'
Total liabilities	1,215,983	522,464	'	'
Equity	'	'	'	'
Total equity	599,351	486,620	'	'
Total liabilities and equity	1,815,334	1,009,084	'	'
Combined Non-Guarantor Subsidiaries [Member]	'	'	'	'
Assets	'	'	'	'
Real estate investments, net of accumulated depreciation	141,207	163,546	'	'
Loans receivable and other investments, net	0	0	'	'
Cash and cash equivalents	4,004	757	754	2,026
Restricted cash	6,377	5,231	'	'
Deferred tax assets	0	0	'	'
Prepaid expenses, deferred financing costs and other assets	7,684	6,134	'	'
Intercompany	0	42,637	'	'
Investment in subsidiaries	0	0	'	'
Total assets	159,272	218,305	'	'
Liabilities	'	'	'	'
Mortgage notes	124,714	141,328	'	'
Secured revolving credit facility	0	0	'	'
Senior unsecured notes	0	0	'	'
Accounts payable and accrued liabilities	1,549	887	'	'
Tax liability	0	0	'	'
Intercompany	5,323	0	'	'
Total liabilities	131,586	142,215	'	'
Equity	'	'	'	'
Total equity	27,686	76,090	'	'
Total liabilities and equity	159,272	218,305	'	'
Elimination [Member]	'	'	'	'
Assets	'	'	'	'
Real estate investments, net of accumulated depreciation	0	0	'	'
Loans receivable and other investments, net	0	0	'	'
Cash and cash equivalents	0	0	0	0
Restricted cash	0	0	'	'
Deferred tax assets	0	0	'	'
Prepaid expenses, deferred financing costs and other assets	0	0	'	'
Intercompany	-1,196,442	-375,956	'	'
Investment in subsidiaries	-1,044,223	-961,350	'	'
Total assets	-2,240,665	-1,337,306	'	'
Liabilities	'	'	'	'
Mortgage notes	0	0	'	'
Secured revolving credit facility	0	0	'	'
Senior unsecured notes	0	0	'	'
Accounts payable and accrued liabilities	0	0	'	'
Tax liability	0	0	'	'
Intercompany	-1,196,442	-375,956	'	'
Total liabilities	-1,196,442	-375,956	'	'
Equity	'	'	'	'
Total equity	-1,044,223	-961,350	'	'
Total liabilities and equity	($2,240,665)	($1,337,306)	'	'

SUMMARIZED_CONDENSED_CONSOLIDA3

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Condensed Consolidating Statement of Income) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues:	'	'	'	'
Rental income	$38,165	$31,699	$111,743	$94,692
Interest and other income	5,819	1,227	16,064	2,531
Total revenues	43,984	32,926	127,807	97,223
Expenses:	'	'	'	'
Depreciation and amortization	9,762	8,258	28,867	24,726
Interest	10,540	9,739	32,668	29,884
General and administrative	6,226	3,057	20,005	11,196
Total expenses	26,528	21,054	81,540	65,806
Loss on extinguishment of debt	-158	-351	-22,454	-10,101
Other income (expense)	-100	300	860	-600
Total other income (expense)	-258	-51	-21,594	-10,701
(Income) loss in subsidiary	0	0	0	0
Net income	17,198	11,821	24,673	20,716
Net Income (Loss) Attributable to Noncontrolling Interest	-6	0	-29	0
Net income attributable to Sabra Health Care REIT, Inc	17,204	11,821	24,702	20,716
Preferred stock dividends	-2,561	-2,579	-7,682	-5,406
Net income attributable to common stockholders	14,643	9,242	17,020	15,310
Basic common share	$0.31	$0.25	$0.39	$0.41
Diluted common share	$0.31	$0.24	$0.39	$0.41
Weighted-average number of common shares outstanding, basic	47,359,949	37,358,334	43,358,620	37,334,120
Weighted-average number of common shares outstanding, diluted	47,877,202	37,828,573	43,840,550	37,777,458
Parent Company [Member]	'	'	'	'
Revenues:	'	'	'	'
Rental income	0	0	0	0
Interest and other income	2	13	9	82
Total revenues	2	13	9	82
Expenses:	'	'	'	'
Depreciation and amortization	13	13	38	38
Interest	0	0	0	0
General and administrative	3,573	2,996	12,133	10,671
Total expenses	3,586	3,009	12,171	10,709
Loss on extinguishment of debt	0	0	0	0
Other income (expense)	0	0	0	0
Total other income (expense)	0	0	0	0
(Income) loss in subsidiary	20,788	14,817	36,864	31,343
Net income	17,204	'	24,702	'
Net Income (Loss) Attributable to Noncontrolling Interest	0	'	0	'
Net income attributable to Sabra Health Care REIT, Inc	17,204	11,821	24,702	20,716
Preferred stock dividends	-2,561	-2,579	-7,682	-5,406
Net income attributable to common stockholders	14,643	9,242	17,020	15,310
Issuers [Member]	'	'	'	'
Revenues:	'	'	'	'
Rental income	0	0	0	0
Interest and other income	0	0	0	0
Total revenues	0	0	0	0
Expenses:	'	'	'	'
Depreciation and amortization	0	0	0	0
Interest	8,435	7,147	24,189	21,585
General and administrative	0	0	2	4
Total expenses	8,435	7,147	24,191	21,589
Loss on extinguishment of debt	0	0	-21,846	-9,750
Other income (expense)	0	0	0	0
Total other income (expense)	0	0	-21,846	-9,750
(Income) loss in subsidiary	29,223	21,964	82,901	62,682
Net income	20,788	'	36,864	'
Net Income (Loss) Attributable to Noncontrolling Interest	0	'	0	'
Net income attributable to Sabra Health Care REIT, Inc	20,788	14,817	36,864	31,343
Preferred stock dividends	0	0	0	0
Net income attributable to common stockholders	20,788	14,817	36,864	31,343
Combined Guarantor Subsidiaries [Member]	'	'	'	'
Revenues:	'	'	'	'
Rental income	33,290	24,380	97,384	72,733
Interest and other income	5,141	1,214	14,039	2,449
Total revenues	38,431	25,594	111,423	75,182
Expenses:	'	'	'	'
Depreciation and amortization	8,288	6,365	24,642	18,983
Interest	749	817	4,642	2,797
General and administrative	2,133	41	6,142	453
Total expenses	11,170	7,223	35,426	22,233
Loss on extinguishment of debt	-158	-351	-472	-351
Other income (expense)	-100	300	860	-600
Total other income (expense)	-258	-51	388	-951
(Income) loss in subsidiary	1,304	982	4,368	2,892
Net income	28,307	'	80,753	'
Net Income (Loss) Attributable to Noncontrolling Interest	0	'	0	'
Net income attributable to Sabra Health Care REIT, Inc	28,307	19,302	80,753	54,890
Preferred stock dividends	0	0	0	0
Net income attributable to common stockholders	28,307	19,302	80,753	54,890
Combined Non-Guarantor Subsidiaries [Member]	'	'	'	'
Revenues:	'	'	'	'
Rental income	4,875	7,319	14,359	21,959
Interest and other income	676	0	2,016	0
Total revenues	5,551	7,319	16,375	21,959
Expenses:	'	'	'	'
Depreciation and amortization	1,461	1,880	4,187	5,705
Interest	1,356	1,775	3,837	5,502
General and administrative	520	20	1,728	68
Total expenses	3,337	3,675	9,752	11,275
Loss on extinguishment of debt	0	0	-136	0
Other income (expense)	0	0	0	0
Total other income (expense)	0	0	-136	0
(Income) loss in subsidiary	0	0	0	0
Net income	2,214	'	6,487	'
Net Income (Loss) Attributable to Noncontrolling Interest	-6	'	-29	'
Net income attributable to Sabra Health Care REIT, Inc	2,220	3,644	6,516	10,684
Preferred stock dividends	0	0	0	0
Net income attributable to common stockholders	2,220	3,644	6,516	10,684
Elimination [Member]	'	'	'	'
Revenues:	'	'	'	'
Rental income	0	0	0	0
Interest and other income	0	0	0	0
Total revenues	0	0	0	0
Expenses:	'	'	'	'
Depreciation and amortization	0	0	0	0
Interest	0	0	0	0
General and administrative	0	0	0	0
Total expenses	0	0	0	0
Loss on extinguishment of debt	0	0	0	0
Other income (expense)	0	0	0	0
Total other income (expense)	0	0	0	0
(Income) loss in subsidiary	-51,315	-37,763	-124,133	-96,917
Net income	-51,315	'	-124,133	'
Net Income (Loss) Attributable to Noncontrolling Interest	0	'	0	'
Net income attributable to Sabra Health Care REIT, Inc	-51,315	-37,763	-124,133	-96,917
Preferred stock dividends	0	0	0	0
Net income attributable to common stockholders	($51,315)	($37,763)	($124,133)	($96,917)

SUMMARIZED_CONDENSED_CONSOLIDA4

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Condensed Consolidating Statement of Cash Flows) (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	$71,239	$49,211
Cash flows from investing activities:	'	'
Acquisitions of real estate	-721,879	-6,175
Acquisition of note receivable	-59,256	-26,393
Preferred equity investment	-11,300	-6,624
Additions to real estate	-1,151	-388
Repayment of loans receivable	287	0
Net proceeds from the sale of real estate	0	2,208
Distribution from subsidiaries	'	0
Investment in subsidiaries	0	'
Intercompany financing	0	0
Net cash used in investing activities	-793,299	-37,372
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	350,000	200,000
Principal payments on senior unsecured notes	-211,250	-113,750
Proceeds from revolving credit facility	699,000	0
Payments on revolving credit facility	-220,500	-92,500
Proceeds from mortgage notes	57,703	0
Principal payments on mortgage notes	-88,419	-10,081
Payments of deferred financing costs	-15,474	-8,598
Issuance of preferred stock	0	138,257
Issuance of common stock	229,825	-2,950
Dividends paid on common and preferred stock	-57,654	-42,677
Contributions from Parent	0	'
Distributions to Parent	'	0
Intercompany financing	0	0
Net cash provided by financing activities	743,231	67,701
Net increase in cash and cash equivalents	21,171	79,540
Cash and cash equivalents, beginning of period	4,308	17,101
Cash and cash equivalents, end of period	25,479	96,641
Parent Company [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	40,289	36,878
Cash flows from investing activities:	'	'
Acquisitions of real estate	0	0
Acquisition of note receivable	0	0
Preferred equity investment	0	0
Additions to real estate	0	0
Repayment of loans receivable	0	'
Net proceeds from the sale of real estate	'	0
Distribution from subsidiaries	'	3,345
Investment in subsidiaries	-12,288	'
Intercompany financing	-182,248	-52,041
Net cash used in investing activities	-194,536	-48,696
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	0	0
Principal payments on senior unsecured notes	0	0
Proceeds from revolving credit facility	0	'
Payments on revolving credit facility	0	0
Proceeds from mortgage notes	0	'
Principal payments on mortgage notes	0	0
Payments of deferred financing costs	0	0
Issuance of preferred stock	'	138,257
Issuance of common stock	229,825	-2,950
Dividends paid on common and preferred stock	-57,654	-42,677
Contributions from Parent	0	'
Distributions to Parent	'	0
Intercompany financing	0	0
Net cash provided by financing activities	172,171	92,630
Net increase in cash and cash equivalents	17,924	80,812
Cash and cash equivalents, beginning of period	3,551	15,075
Cash and cash equivalents, end of period	21,475	95,887
Issuers [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	0	0
Cash flows from investing activities:	'	'
Acquisitions of real estate	0	0
Acquisition of note receivable	0	0
Preferred equity investment	0	0
Additions to real estate	0	0
Repayment of loans receivable	0	'
Net proceeds from the sale of real estate	'	0
Distribution from subsidiaries	'	3,345
Investment in subsidiaries	-12,288	'
Intercompany financing	-915,786	-132,883
Net cash used in investing activities	-928,074	-129,538
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	350,000	200,000
Principal payments on senior unsecured notes	-211,250	-113,750
Proceeds from revolving credit facility	604,000	'
Payments on revolving credit facility	0	0
Proceeds from mortgage notes	0	'
Principal payments on mortgage notes	0	0
Payments of deferred financing costs	-9,212	-5,408
Issuance of preferred stock	'	0
Issuance of common stock	0	0
Dividends paid on common and preferred stock	0	0
Contributions from Parent	12,288	'
Distributions to Parent	'	-3,345
Intercompany financing	182,248	52,041
Net cash provided by financing activities	928,074	129,538
Net increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Combined Guarantor Subsidiaries [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	0	0
Cash flows from investing activities:	'	'
Acquisitions of real estate	-713,778	-6,175
Acquisition of note receivable	-59,256	-26,393
Preferred equity investment	-11,300	-6,624
Additions to real estate	-1,128	-388
Repayment of loans receivable	287	'
Net proceeds from the sale of real estate	'	0
Distribution from subsidiaries	'	0
Investment in subsidiaries	0	'
Intercompany financing	0	0
Net cash used in investing activities	-785,175	-39,580
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	0	0
Principal payments on senior unsecured notes	0	0
Proceeds from revolving credit facility	95,000	'
Payments on revolving credit facility	-220,500	-92,500
Proceeds from mortgage notes	0	'
Principal payments on mortgage notes	0	0
Payments of deferred financing costs	-5,111	-3,011
Issuance of preferred stock	'	0
Issuance of common stock	0	0
Dividends paid on common and preferred stock	0	0
Contributions from Parent	0	'
Distributions to Parent	'	0
Intercompany financing	915,786	135,091
Net cash provided by financing activities	785,175	39,580
Net increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Combined Non-Guarantor Subsidiaries [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	30,950	12,333
Cash flows from investing activities:	'	'
Acquisitions of real estate	-8,101	0
Acquisition of note receivable	0	0
Preferred equity investment	0	0
Additions to real estate	-23	0
Repayment of loans receivable	0	'
Net proceeds from the sale of real estate	'	2,208
Distribution from subsidiaries	'	0
Investment in subsidiaries	0	'
Intercompany financing	0	0
Net cash used in investing activities	-8,124	2,208
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	0	0
Principal payments on senior unsecured notes	0	0
Proceeds from revolving credit facility	0	'
Payments on revolving credit facility	0	0
Proceeds from mortgage notes	57,703	'
Principal payments on mortgage notes	-88,419	-10,081
Payments of deferred financing costs	-1,151	-179
Issuance of preferred stock	'	0
Issuance of common stock	0	0
Dividends paid on common and preferred stock	0	0
Contributions from Parent	12,288	'
Distributions to Parent	'	-3,345
Intercompany financing	0	-2,208
Net cash provided by financing activities	-19,579	-15,813
Net increase in cash and cash equivalents	3,247	-1,272
Cash and cash equivalents, beginning of period	757	2,026
Cash and cash equivalents, end of period	4,004	754
Elimination [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	0	0
Cash flows from investing activities:	'	'
Acquisitions of real estate	0	0
Acquisition of note receivable	0	0
Preferred equity investment	0	0
Additions to real estate	0	0
Repayment of loans receivable	0	'
Net proceeds from the sale of real estate	'	0
Distribution from subsidiaries	'	-6,690
Investment in subsidiaries	24,576	'
Intercompany financing	1,098,034	184,924
Net cash used in investing activities	1,122,610	178,234
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	0	0
Principal payments on senior unsecured notes	'	0
Proceeds from revolving credit facility	0	'
Payments on revolving credit facility	0	0
Proceeds from mortgage notes	0	'
Principal payments on mortgage notes	0	0
Payments of deferred financing costs	0	0
Issuance of preferred stock	'	0
Issuance of common stock	0	0
Dividends paid on common and preferred stock	0	0
Contributions from Parent	-24,576	'
Distributions to Parent	'	6,690
Intercompany financing	-1,098,034	-184,924
Net cash provided by financing activities	-1,122,610	-178,234
Net increase in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	$0	$0

PRO_FORMA_FINANCIAL_INFORMATIO2

PRO FORMA FINANCIAL INFORMATION (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Business Acquisition [Line Items]	'	'	'	'
Weighted-average number of common shares outstanding, basic	47,359,949	37,358,334	43,358,620	37,334,120
Weighted-average number of common shares outstanding, diluted	47,877,202	37,828,573	43,840,550	37,777,458
Series of Individually Immaterial Business Acquisitions [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Business Acquisition, Pro Forma Revenue	53,706	46,572	160,491	138,159
Business Acquisition, Pro Forma Depreciation and Amortization	13,483	13,004	40,573	38,933
Business Acquisition, Pro Forma Net Income (Loss)	22,456	16,328	40,221	39,818
Business Acquisition, Pro Forma Earnings Per Share, Basic	0.47	0.44	0.93	1.07
Business Acquisition, Pro Forma Earnings Per Share, Diluted	0.47	0.43	0.92	1.05
Skilled Nursing Transitional Care Facilities [Member] | Series of Individually Immaterial Business Acquisitions [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Number of acquired properties	'	'	6	'
Senior Housing Facilities [Member] | Series of Individually Immaterial Business Acquisitions [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Number of acquired properties	'	'	27	'

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)	0 Months Ended			9 Months Ended		1 Months Ended	0 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jul. 30, 2014	5-May-14	Jan. 23, 2014	Sep. 30, 2014	Sep. 30, 2013	Nov. 03, 2014	Nov. 03, 2014
				Investment		Subsequent Event [Member]	Subsequent Event [Member]
						Investment	Dividend Declared [Member]
						Facilities
Subsequent Event [Line Items]	'	'	'	'	'	'	'
Common dividends, declared	$0.38	$0.38	$0.36	$1.12	$1.02	'	$0.39
Preferred stock dividends, declared	'	'	'	'	'	'	$0.45
Payments to Acquire Real Estate Held-for-investment	'	'	'	'	'	$81.70	'
Number of Facilities in Investment	'	'	'	'	'	4	'
Number of Investments	'	'	'	18	'	1	'